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This thesis was designed to explore the nature of risk-taking behaviour in people 
diagnosed with Bipolar Disorder (BD).  Research has traditionally attributed risk-taking 
behaviour in BD to difficulties in impulse control.  Nonetheless, impulsivity remains 
predominantly measured using self-report questionnaires, with dubious validity.  The links 
between impulsivity and risk-taking have also been challenged by new research in the field of 
decision-making suggesting a different conceptualisation of this often misunderstood set of 
behaviours.  In particular, Fuzzy Trace Theory (FTT) offers an interesting framework to 
understand risk-taking as a “rational/deliberate” act, rather than an impulsive one, providing 
evidence for a “reasoned route” to risk-taking.   
This piece of research comprised of a systematic review, an empirical paper and a 
critical appraisal.  The aim of the systematic review was to clarify whether there is consistent 
evidence to suggest that risk-taking behaviours are more prevalent in people diagnosed with 
BD compared to controls.  Clinical and demographic predictors of risk-taking in BD were 
also explored.  The research paper aimed at characterising a group of people with BD in the 
context of FTT and to explore whether measures of FTT were predictive of higher risk-taking 
tendencies after controlling for impulsivity and mood.  Finally, the critical appraisal aimed at 
discussing the dilemma of conducting quantitative research as a trainee clinical psychologist. 
The review suggested that people diagnosed with BD are more likely to engage in 
risk-taking behaviour, but that this is dependent on mood state and mainly prevalent during 
states of mania.  Some evidence in support of clinical and demographic predictors of risk-
taking in BD was also found.  The empirical paper also supported the hypothesis that FTT 
predicts risk-taking behaviour, even after accounting for the effects of mood and impulsivity.  
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Objectives.  This systematic review aimed at clarifying the links between risk-taking 
behaviours and the different mood states of bipolar disorder.  It also aimed at identifying any 
demographic and clinical predictors of elevated risk-taking in people diagnosed with bipolar 
disorder. 
Methods.  A systematic computerised search of the main bibliographical databases 
(PsycINFO, CINAHL and Medline) was conducted.  Electronic searches were supplemented 
by hand-searching and articles that met inclusion criteria were included for consideration.  A 
total of 23 studies were identified, which consisted of cross-sectional and case-control studies 
investigating risk-taking behaviours in bipolar disorder through behavioural tasks and self-
report questionnaires. Both clinical and non-clinical samples were included. 
Results.  Higher rates of risk-taking behaviours during manic states of bipolar disorder were 
consistently reported in 12 out of 13 studies involving self-report measures, but not in studies 
involving behavioural tasks.  Only one study found evidence for higher risk-taking during 
depressive states and no study during euthymia.  There was also preliminary evidence in 
support of demographic and clinical predictors of risk-taking behaviours in bipolar disorder. 
Limitations.  This review had several limitations.  There were many studies adopting a cross-
sectional design and not including a control group, which made it challenging to interpret 
results and comment on generalisability.  Finally, it was not possible to establish causality 
between variables as only correlations were reported. 
Conclusions.  This review found evidence in support of the idea that risk-taking behaviours 
are limited to the (hypo)manic states of bipolar disorder.  Nonetheless, there were some 
limitations in the studies included for review, thus results need to be interpreted cautiously.  
Further research is needed to help clarify the nuances behind risk-taking in this population.   
Keywords.  Bipolar disorder, (hypo)mania, risk-taking behaviour 




Risk-taking in bipolar disorder: A systematic review 
1. Introduction 
Bipolar disorder (BD) is defined as a cyclical condition involving episodes of significant 
impairment of mood and behaviour, intermixed with periods of full or partial recovery and 
improved functioning (National Collaborating Centre for Mental Health, 2014).  Due to its 
cyclical and heterogeneous nature, BD is often difficult to characterise (Angst, 2013).  The 
main criteria of the Diagnostic and Statistical Manual of Mental Disorders 5th Edition 
diagnosis of BD include “presence of five out of nine diagnostic symptoms with a minimum 
duration of 2 weeks” and a “change from previous functioning” (DSM-5; American 
Psychiatric Association, 2013).   
The publication of the DSM-5 saw several changes to the way BD is characterised in 
diagnostic terms.  These changes were mainly a response to a main critique brought forward 
for the DSM-4, which identified a trend towards under-diagnosis of BD (e.g., Ghaemi et al., 
1999).  One of the main changes in the DSM-5 was the introduction of new subcategories of 
BD diagnosis and the introduction of the idea of a “bipolar spectrum” in an attempt to 
increase its diagnostic validity (Angst, 2013).  Nonetheless, the validity of BD diagnosis has 
been put under scrutiny in recent years, particularly following the publication of the DSM-5, 
which was criticised for potentially blurring the boundaries between psychiatric diagnosis 
and “normal human experiences” (e.g., Phillips & Kupfer, 2013). 
Despite its shortcomings, psychiatric diagnosis remains the most utilised characterisation 
of mental health difficulties, particularly within quantitative research.  Therefore, for the 
purpose of this paper DSM-5 diagnosis of BD will be utilised as a criterion to categorise the 
papers included.      
BD is considered one of the most disabling health conditions, ranked 4th for disability-
adjusted life-years in people aged 10-24 (Gore et al., 2011).  One of the contributing 




problems associated with this disability, are the negative consequences associated with 
engagement in risk-taking behaviours, such as impulsive overspending and risky sexual 
practices (Blanco et al., 2008; Chamorro et al., 2012; Christopher et al., 2012).  
Risk-taking behaviours can have devastating consequences for people diagnosed with 
BD in several domains, both in the short term and in the longer term.  There is a strong 
association between drugs/alcohol abuse and BD (Nesvåg et al., 2015).  BD has also been 
linked with pathological gambling (Kim et al., 2006), which could be understood as the result 
of a higher likelihood to engage in excessive spending sprees, typical of the manic stages of 
the condition.  BD has also been found to be related to impulsive suicide (Clements et al., 
2013), which is of high relevance when conceptualising risk-taking behaviours in this clinical 
population.     
In addition to the immediate negative impact of risk-taking, these behaviours have 
also been associated with long-term negative consequences.  Engagement in risk-taking 
activities can lead to damage in relationships, contributing to a lack of social support, which 
has been linked to worse outcome in BD (Altman et al., 2006).  Finally, psychological 
theories of BD suggest that risk-taking behaviours are often regretted when the mania 
subsides, leading to intense feelings of guilt and shame that can in turn contribute to the start 
of a depressive episode (Lam et al., 2010).     
There has been an increased interest in risk-taking behaviours in BD in the recent 
years.  Studies in the field have attributed risk-taking to impairments in decision making, 
involving executive function, memory, attention and cognitive flexibility, which have been 
observed in neuroimaging studies of people diagnosed with BD (Martínez-Arán et al., 2004; 
Robinson et al., 2006; Robinson and Ferrier, 2006).  However, although there is evidence for 
decision-making impairments across mood states of BD, the ways in which risk-taking 




behaviours change between the manic, depressed and euthymic states of the condition remain 
poorly understood.   
1.1. Decision making and risk-taking in bipolar disorder 
 Decision-making is essential to daily functioning; during their lives individuals are 
faced with contrasting alternatives to choose from in order to reach a certain outcome (Ibanez 
et al., 2012).  Selecting between two or more, often contrasting, choices is a process that 
involves some degree of risk-taking.  In fact, making decisions usually involves a careful 
trade-off of risks and benefits to select the option with the most benefit for a particular person 
(Mishra, 2014).    
Decision-making is a complex cognitive ability that involves a close interaction 
between different areas of the brain responsible for attention, learning, memory, motivation 
and emotion (Bechara et al., 2000; Brand et al., 2006).  As people progress from childhood to 
adulthood, these neurological circuits undergo a process of maturation that leads to an 
improvement in decision making abilities with age (Reyna et al., 2015; Reyna and Farley, 
2006; Tymula et al., 2013), up to the stages of later life (65+ years), where there is a rapid 
decline in general cognitive functioning and decision-making (Tymula et al., 2013).  
Therefore, it can be inferred that a disruption in this maturation can contribute to impairments 
in decision making. 
There is evidence that BD progression is associated with impairments in memory, 
attention and executive function (Robinson et al., 2006).  Difficulties in decision making 
abilities, in particular decisions involving risk, are now included in clinical descriptions of 
both bipolar depression and mania (American Psychiatric Association, 2013) and supported 
by research in the field.  Euthymic clients with BD have also been shown to present with 
neurocognitive impairments related to attention, executive processing and memory (Glahn et 
al., 2006), which have been linked with an increased focus on potential gains rather than 




losses (Yechiam et al., 2008).  Also, BD has been characterised by an increased tendency to 
work towards a reward, often without sufficient planning (Johnson and Carver, 2012; Mason 
et al., 2014), and has been associated with impairments in emotional regulation and executive 
functioning (Green et al., 2007), all instrumental factors that when not working appropriately, 
have been linked to risk-taking in non-clinical populations (Magar et al., 2008), leading to 
risk-taking behaviours in people with BD too (Yechiam et al., 2008).   
Clients diagnosed with BD have also been found to score higher than people 
diagnosed with schizophrenia and unipolar depression on measures of extraversion and 
openness to experience (Bagby et al., 1997), which have been associated to high levels of 
risk-taking behaviours in non-clinical populations (Lauriola and Levin, 2001; Nicholson et 
al., 2005).   
These findings provide evidence to show a tendency towards risky behaviour in BD, 
which has been associated with different levels of impairment in multiple brain systems, 
which could be some of the mechanisms behind risk-taking behaviours in both non-clinical 
populations and in people diagnosed with BD.  Nonetheless, research in the field is still 
conflicting regarding possible changes in decision-making abilities across different mood 
episodes and euthymic stages of BD.  Whilst some studies report impaired performance in 
neurocognitive tests of risk-taking, such as the Iowa Gambling Task (IGT; Christodoulou et 
al., 2006; Martino et al., 2011) in euthymic clients with BD, other studies found that there 
was no difference in scores on decision-making tasks between euthymic clients with BD and 
healthy controls (Clark et al., 2002; Rubinsztein et al., 2006).   
Studies conducted with non-clinical populations at risk for (hypo)mania are also of 
high relevance.  There is evidence to show that a higher tendency to engage in risk-taking 
behaviours is not limited to people with an established diagnosis of BD, but it may also be 




present in people at risk for (hypo)mania who do not have a formal diagnosis (e.g., 
Richardson and Garavan, 2010). 
There has been some progress in the study of decision making and risk-taking in BD, 
however there are aspects that require further study.  For example, despite some studies 
proposing impairments in different areas involved in decision-making involving risk in BD, it 
remains unclear whether increased risk-taking is a stable feature of BD or whether the 
observed impairments vary across the manic, depressive and euthymic mood states of the 
condition. 
Studying risk-taking behaviour in BD, particularly during states of mania, poses a 
significant challenge; research found that people experiencing (hypo)mania may enjoy the 
positive emotions associated with it and may covet the initial stages of a manic episode (Lam 
et al., 2005; Lobban et al., 2012).  The positive experiences reported during states of mania 
can contribute to the ambivalence to treatment, which is often observed in people 
experiencing (hypo)mania (Lobban et al., 2012).  People in (hypo)manic states of BD often 
describe mania as a “welcome holiday” from the frequent periods of depression, thus 
experiencing a conflict around the management of (hypo)mania (Fletcher et al., 2013) 
  Therefore, further increasing our understanding of risk-taking and the mechanisms 
behind this behaviour could be beneficial as it could contribute to the design of interventions 
that clients can engage with and that can build on clients’ strengths to increase positive 
experiences and reduce the negative impact of BD.  In particular, exploring studies involving 
non-clinical populations is important to clarify the mechanisms behind the development of 
risk-taking behaviours in BD. 
At present, there are no systematic reviews available that specifically investigate risk-
taking in people diagnosed with BD.  The aim of this paper is to systematically review the 
literature on risk-taking in BD. The following research questions will be addressed: 




1. Is there evidence for a higher likelihood of risk-taking behaviours of BD 
compared to the general population? 
2. Are there differences in type of risk-taking behaviours between mood states of 
BD? 
3. Are there any identifiable demographic and clinical predictors of risk-taking in 
BD? 
2. Method 
A systematic review of the literature was conducted of papers investigating risk taking 
in people diagnosed with bipolar disorder. 
2.1.  Search Strategy 
The following databases: PsycINFO, CINAHL and Medline were searched for 
relevant articles.  The search terms used were: (“risk taking” OR “high-risk behaviour” OR 
“risky behaviour”) AND (“bipolar disorder” OR “mania”).  Electronic searches were 
supplemented by hand searching the reference list of the articles deemed appropriate for 
inclusion as well as other key articles on the topic.  Studies were selected by reading the titles 
and abstracts of the articles retrieved to assess for suitability.  The opinion of a second 
reviewer was requested when in doubt. 
2.2.  Study Selection 
Studies were assessed for suitability based on the following inclusion criteria: 
1. Quantitative studies including clinical samples with a diagnosis of Bipolar Disorder or 
non-clinical samples assessed for hypomania. 
2. Studies investigating risk-taking behaviour through self-report questionnaires and/or 
behavioural measures. 
3. Studies published in peer-reviewed journals in English. 




Studies were excluded if one (or more) of the following conditions were met: 
1. Qualitative studies; this was due to the difficulty in comparing qualitative reports with 
more objective measures of risk-taking. 
2. Studies in a language other than English. 
3. Review studies. 
4. Studies utilising measures of decision-making which were not specifically related to 
risk-taking. 
5. Studies including aggregated samples with more than one psychiatric diagnosis, 
where it would have been challenging to extract meaningful results specifically 
applying to the BD group. 
6. Neuroimaging studies; it was beyond the scope of this review to analyse papers 
providing findings from neuroimaging tests. 
A flowchart of the selection process, including the number of studies retrieved at each stage, 
is presented in Figure 1.  A total of 23 studies were included for review. 
2.3. Quality control 
Reporting bias was assessed using the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) Statement tool for cross-sectional, cohort and case-
report studies (von Elm et al., 2014).  Studies were scored on individual items and the final 
total scores were commuted into percentages.  Discrepancies were discussed with a second 
rater, GPA on a need basis.  Studies were not excluded based on quality due to the paucity of 
papers in the field.  A summary of findings is reported in the result section and in Table 1.  
3. Results 
3.1.  Study Characteristics  




An overview of the characteristics of the studies included in the current review (n=23) 
is presented in Table 2.  Participants’ mean age ranged from 15 to 45.  Studies included both 
clinical (n=19) and non-clinical (n=4) samples.  The design of the individual studies varied; 
16 studies were case-control and 7 were cross-sectional.  Sample sizes ranged significantly 
(34 to 720), with a trend towards larger samples in studies involving non-clinical groups.  
3.2.  Reporting Quality 
The reporting quality of individual papers based on the STROBE tool for cross-
sectional and case-control studies ranged from 29% to 76%, where high values means good 
quality.  The quality of the papers was generally good across all sections (M = 62%, SD = 
11.08), with most papers reporting eligibility criteria, key findings, limitations and a balanced 
interpretation of the results.  Most studies (n=19), also reported the role of funding sources 
and potential conflict of interests.  Nonetheless, common issues were identified across them; 
no study included information on how potential sources of bias were addressed.  Most studies 
also did not report details of how the participants sample was arrived at and how missing 
variables were handled.  Power calculations were never reported. 
3.3.  Key Findings 
The aim of the current review was to summarise findings from quantitative studies 
investigating risk-taking in people diagnosed with BD and non-clinical samples assessed for 
hypomania.  Overall findings regarding higher risk-taking in BD were mixed, particularly due 
to the variety of different measures of risk-taking adopted by each study included in this 
review, and need to be interpreted cautiously.  Results from individual studies offered some 
evidence for the presence of individual predictors of risk-taking behaviours in BD.  More 
information is reported below. 
To answer the three research questions, findings were organised using the following 
criteria: first, data providing evidence for and against the presence of risk-taking behaviours 




in BD was presented.  This initial section was divided into two subsections presenting 
findings from studies utilising behavioural measures and findings coming from self-report 
questionnaires.  Information about differences in mood states was integrated in this section.  
Finally, data from studies reporting on predictors of risk-taking in BD was summarised. 
3.4.  Risk-Taking Behaviours in BD and mood states 
3.4.1. Findings from behavioural measures 
In total, 47% (n=11) of the studies used behavioural measures of risk-taking; these 
included the Iowa Gambling Task (IGT; n=4), the Balloon Analogue Risk Taking Task 
(BART; n=4), the Cambridge Gambling Task (CGT; n=1), the Affective Go/No Go Test 
(AGNT; n=1), a Risky Choice Task (n=1) and a Framed Risky Choice Task (n=1).   
Results from these studies were contrasting.  Two studies (Adida et al., 2008; 2011) 
found people diagnosed with BD in manic, depressed and euthymic phases to perform 
significantly worse on the IGT than healthy controls.  Nonetheless, one study (Edge et al., 
2013) involving a sample of people in remission from BD-I reported no significant 
differences in scores between the BD-I and the control groups.  Similarly, another study 
(Martino et al., 2011) involving a sample of people in a euthymic stage of BD found no 
significant differences between the BD and the control groups in the IGT.   
 Results for the BART showed a more consistent trend of results.  The majority of 
studies adopting the BART (n=4) found no differences in overall BART performance 
between people diagnosed with BD and control groups. However,  Hıdıroğlu et al. (2013) 
reported that the BD group and their first-degree relatives showed impaired learning trends in 
the BART, represented by lower adjustment scores after the loss of a temporary gain.  Only 
two studies found a difference in BART scores between BD and control groups. Holmes et al. 
(2009) found that people with BD and a history of alcohol abuse performed significantly 
worse than both people with BD without a history of alcohol abuse and healthy controls.  




Moreover, a study  involving a non-clinical sample of adults from the community (Devlin et 
al., 2015), found that people with a higher hypomania score measured by the Hypomania 
Personality Scale  (HPS) showed poorer performance in the BART than people with a lower 
hypomania risk.   
Interestingly, Roisier et al. (2009) adopted a mood induction paradigm to test the 
hypothesis that decision-making impairments are limited to the manic stages of BD.  Results 
showed that, following positive mood induction, which mimics (hypo)mania, people in 
remission from BD showed slower decision making on the CGT (measured by longer 
deliberation time), but no impairments in general CGT performance compared to controls.  
Finally, two studies involving a framed risky choice task based on a series of dilemmas 
involving two gambles (Chandler et al., 2009) and a risky choice task where participants were 
required to choose between two simultaneously presented gambles  (Saunders et al., 2016), 
found no differences in general tendency for risk-taking between the BD and the healthy 
control group. 
 In summary, 8 out of 11 studies (73%) involving behavioural measures did not find 
differences in risk-taking between BD or (hypo)mania compared to controls when measures 
of risk-taking are taken into account.   
3.4.2. Self-report measures 
 Thirteen studies (56%) used self-report measures to assess risk-taking.  Among these, 
9 (69%) involved clinical samples.  Findings were consistent across studies, both in clinical 
and non-clinical samples, where BD mania and higher hypomania risk were found to be 
associated with more risk-taking behaviours.   
Studies involving clinical samples found that BD people in a manic state scored 
higher than healthy controls and people diagnosed with a Major Depressive Episode on risk-
taking self-report measures (Goldberg et al., 2005)




reported to have been more frequently diagnosed with a sexually transmitted disease, have 
had sex with casual partners, non-monogamous partners and partners with HIV unknown 
condition than healthy controls, behaviours that are considered to be markers of risk-taking.  
Nonetheless, further analysis showed that higher risk-taking behaviours were associated with 
younger age at onset, longer diagnostic delay and higher number or (hypo)manic episodes 
(Marengo et al., 2015).   
Hariri et al., (2011) found no significant differences between people diagnosed with 
BD and the control group on the likelihood to engage in risky sexual behaviours.  One study 
(Fletcher et al., 2013) involving people in euthymic, manic and depressed states of BD found 
that this group reported a higher likelihood to overspend and engage in risky sexual 
behaviours than the control group.  Nonetheless, further analysis showed that these 
differences were related to alcohol abuse, with participants reporting increased use of alcohol 
during manic stages to be one of the reasons behind the increase in risky sexual behaviours 
and overspending.  Another study found that 46% of adolescents diagnosed with BD reported 
a positive history of sexual risk behaviour in the past year (Bakare et al., 2009).  Nonetheless, 
there was no control group and the study involved a sample of adolescents, who are known to 
be a high-risk group for sexual risk behaviours, regardless of BD diagnosis (Potard et al., 
2008).  
 Two studies involving a sample of people diagnosed with BD who were also HIV 
positive found that BD was associated with sex with commercial partners, sex outside the 
primary relationship, smoking and excessive drinking before the HIV diagnosis, illicit drug 
use before and after the HIV diagnosis (de Sousa Gurgel et al., 2013), unprotected sex with 
HIV negative partners in the past 6 months (Meade et al., 2012) compared to the US general 
population and people without a BD diagnosis respectively.  BD was also found to be 
associated with a lower adherence to Antiretroviral (ARV) treatment, in particular in people 




who reported having had unprotected intercourse with HIV negative partners and who had 
greater symptoms of mania and depression (Meade et al., 2012), compared to controls. 
 Finally, two studies involving a sample of people diagnosed with BD with comorbid 
substance use disorder (SUD) found that they reported high rates of having had unprotected 
sex, multiple sexual partners (Meade et al., 2008; 2011), sex with prostitutes and injection 
drug use (Meade et al., 2008).  Meade and colleagues (2008) compared rates from their 
sample with available rates from the US general population and found that their sample had 
higher rates of risk-taking behaviours.  
Similar trends were observed in non-clinical samples, where hypomania risk was 
found to be associated with increased expected involvement in risk-taking activities in the 
next 6 months (Devlin et al., 2015).  There were significant correlations between higher 
overall scores on the Domain-Specific Risk-Taking (DOSPERT) scale and higher hypomania 
scores as measured by the HCL-32 (Richardson & Garavan, 2010).  There was no 
relationship between DOSPERT subscales and hypomania risk, suggesting that hypomania is 
related with general risk-taking but not with a specific type of risk taking.  Dvorak et al., 
(2013) found that high-risk for mania was only associated with a higher likelihood to engage 
in risky sexual events when there was low effortful control measured by the UPPS-P 
Impulsive Behaviour Scale, but not when effortful control was high.  Finally, in one study 
(Stewart et al., 2012) adolescents with elevated symptoms of mania (ESM+; Mean Age 
14.89, SD=1.31) were found to be more likely to have had vaginal/anal sex, have had two or 
more partners in the last 90 days, test positive for STIs, have had unprotected sex and 
exchange sex for money, drugs or shelter than adolescents who did not meet (sub)threshold 
criteria for mania.  
 In summary, studies using self-report measures showed a more consistent pattern of 
significant associations between BD and (hypo)mania than studies involving behavioural 




measures. In total, 12 studies (92%) involving self-report measures found evidence of 
elevated risk-taking in people diagnosed with BD and non-clinical groups at risk of 
hypomania, whilst only one study found no differences between BD and control groups on 
risk-taking behaviours. 
3.5.  Predictors of risk-taking 
 In total, 14 studies (61%) reported on predictors of risk-taking behaviours in BD.  
Some demographic predictors were found; older age was found to be a significant predictor 
of a higher likelihood of having engaged in risky sexual behaviours in the past six months in 
a non-clinical sample of university students assessed for (hypo)mania risk (Dvorak et al., 
2013).  Interestingly, no associations between age and risk-taking were found in a sample of 
people diagnosed with BD Type 1 (Edge et al., 2013).   Low level of education was also 
reported as a significant predictor of higher risk-taking (Adida et al., 2011).  However, Edge 
et al. (2013) found no relationship between level of education and risk-taking.  In this study, 
marital status of the parents was found to be a significant predictor of higher-risk taking, with 
children of single parents reporting to be more likely to engage in sexual risk-taking.   
 The role of impulsivity in predicting risk-taking behaviours was also explored in 
individual studies.  Three out of four studies reported impulsivity to be significantly 
correlated with higher risk-taking (Hidiroglu et al., 2013; Holmes et al., 2009; Richardson et 
al., 2010).  One study found impulsivity not to be a significant predictor of higher risk-taking 
(Edge et al., 2013).  Findings were mixed regarding the type of impulsive behaviour related 
to higher risk taking; Hidiroglu et al. (2013) found higher scores on the Barratt Impulsiveness 
Scale (BIS) Total, BIS-Attentional, BIS-Motor and BIS-Non Planning scales to be predictive 
of higher risk-taking, whilst Richardson et al. (2010) only found significant associations 
between the BIS-Attentional and BIS-Motor subscales with higher scores on the HCL-32 
Risk-Taking/Irritable subscale.  Similarly, Holmes et al. (2009) only found higher BIS-Motor 




subscale scores to be associated with higher risk-taking, measured by more balloon popped 
on the BART, whilst they found no correlations between the BIS-Attentional and BIS-Non 
Planning subscales with scores on the BART.  Finally, Edge et al. (2013) found no 
relationship between impulsivity scores and risk-taking in a sample of participants diagnosed 
with BD Type 1.  
 There were some significant associations between mood state and risk-taking.  Adida 
et al. (2011) reported high depression ratings (as measured by HDRS scores) to be a 
significant predictor of higher risk-taking.  Meade et al. (2012) also found greater symptoms 
of depression to be associated with a higher likelihood of having sex with HIV negative 
partners in a sample of participants with BD who were HIV positive.  Meade et al. (2011) 
found depression to be unrelated to higher sexual risk behaviour.  Marengo et al. (2015) 
found higher number of depressive and (hypo)manic episodes to be correlated with repeated 
STIs.  A recent manic episode (Meade et al., 2008), more average weeks of mania (Meade et 
al., 2011) and greater severity of mania (Meade et al., 2012) were also associated with a 
higher likelihood to engage in sexual risk-behaviours.  Edge et al. (2013) found mood state 
not to be a significant predictor of a higher likelihood to engage in risk-taking. 
 Several studies reported on clinical variables; longer duration of illness, higher 
number of previous episodes of BD, higher number of hospitalisations (Hidiroglu et al., 
2013), younger age at onset of BD and longer diagnostic delay (Marengo et al., 2015) were 
all significant predictors of higher risk-taking.  Interestingly, lower severity of BD symptoms 
was associated with higher HIV risk in a study involving people diagnosed with BD who 
tested positive for HIV (Meade et al., 2008).  Edge et al. (2013) found illness severity (higher 
number of previous episodes of BD and hospitalisations) not to be a significant predictor of 
higher risk-taking.  Suicide was also linked with risk-taking; one study found history of 
suicide attempts to be a significant predictor of a higher likelihood to engage in risk-taking 




behaviours (Martino et al., 2011).  Edge et al. (2013) found number of suicide attempts not to 
be significantly associated with rates of risk-taking and BD type not to be a significant 
predictor of risk-taking.   
 Individual studies reported a relationship between medication and risk-taking.  
Namely, use of benzodiazepine, non-use of SNRI antidepressants (Adida et al., 2011), poorer 
adherence to psychiatric medication (Meade et al., 2012) and taking antipsychotic medication 
(Reddy et al., 2014) were all significant predictors of higher rates of risk-taking.  Use of 
mood stabilisers was not found to be related to higher risk-taking (Edge et al., 2013). 
Among other predictors reported in individual studies, lack of insight (Adida et al. 2008), 
sensation-seeking (Dvorak et al., 2013), family history of BD (Adida et al., 2011), presence 
of co-morbid disorders (Bakare et al., 2009), history of substance abuse (Marengo et al., 
2015), greater drug severity (Meade et al., 2008) and cocaine use (Meade et al., 2011) were 
all associated with higher rates of risk-taking. 
 Some protective factors were also identified; Bakare et al. (2009) found that 
high/moderate levels of religious activities were protective against risk-taking.  Dvorak et al. 
(2013) reported that effortful control was protective against risk-taking in a community 
sample of university students; however, this relationship was only observed for participants at 
high risk for mania. 
4. Discussion 
 The papers included in the current review yielded interesting findings to help clarify 
the nuances of how heightened risk-taking manifests in the BD population and people with 
high levels of hypomania.  The discussion section was divided into two main areas to address 
the three research questions of this review:  first, findings on rates of risk-taking in BD and 
differences in risk-taking across mood states are discussed.  Subsequently, an interpretation 
of the results about predictors of risk-taking is presented. 




4.1.  Risk-taking in BD and differences across mood states 
Overall, the results of the current review were mixed regarding the idea that BD is 
characterised by higher risk-taking than the general population.  Interestingly, some 
variability was observed when method of evaluation was considered; studies involving 
behavioural tasks showed less conclusive findings than those involving self-report measures, 
therefore results must be interpreted cautiously.    
Studies involving behavioural tasks used a variety of measures to assess risk-taking, 
which makes it difficult to interpret their findings.  Overall, studies using the IGT as a 
measure of risk-taking found a trend for higher risk-taking in people who were experiencing a 
manic or depressed mood state, whilst there were no differences between people in remission 
from or in euthymic stages of BD and control groups on IGT scores.  Similar trends were 
observed in studies using the BART, where no differences were found between people in 
remission from or in euthymic stages of BD and control groups in BART scores.  
Studies involving self-report measures showed more consistent findings than studies 
involving behavioural measures, reporting higher risk-taking behaviours in people 
experiencing a manic episode of BD or in non-clinical samples with elevated scores of 
(hypo)mania.  This pattern was not observed in euthymic samples or non-clinical samples 
with low scores.  Only three studies found evidence of higher risk-taking in participants with 
BD who were not experiencing a manic episode (Bakare et al., 2009; Fletcher et al., 2013b; 
Marengo et al., 2015).  Nonetheless, Fletcher et al. (2013) reported that alcohol abuse during 
mania was a possible explanation for the observed higher rates of risky sexual behaviours and 
overspending during these states.  Alcohol use has been associated with an increased 
likelihood to engage in risk-taking behaviours (e.g., Gayson et al., 2015), thus the effects of 
alcohol need to be taken into account when interpreting these results.  Interestingly, Marengo 




et al. (2015) found that higher risk-taking was associated with number of manic episodes 
experienced. 
Finally, Bakare et al., (2009) recruited a group of adolescents diagnosed with BD.  
Adolescence has consistently been associated with a higher likelihood to engage in risk-
taking behaviours (e.g., Potard et al., 2008), therefore it is likely that the findings observed 
are a result of the age group involved in the study rather than their clinical characteristics.  
Moreover, it is important to note that the study did not include a control group, thus the 
“high” rates of risk-taking behaviours reported appear to be based on subjective interpretation 
by the authors. 
In summary, the results of the current review suggest that risk-taking could be 
conceptualised as a state marker of mania, rather than an endophenotype of BD.  In support 
of this claim, Hıdıroğlu et al. (2013) found no differences between first-degree relatives of 
people with BD and healthy controls in BART scores.  Moreover, (Devlin et al., 2015) found 
higher (hypo)mania risk to be associated with poorer performance on the BART in a non-
clinical sample of adults from the community.  A finding which is particularly noteworthy 
comes from Roiser et al., (2009) who found that, following mood induction, which mimics 
(hypo)mania,  people in remission from BD showed slower decision making on the CGT, but 
no impairments in general CGT performance compared to controls.  However, it is important 
to note that the study by Roiser et al., (2009) involved a small sample of 15 volunteers, thus it 
is difficult to comment on the generalizability of their findings. 
Research in the field of BD has shown evidence for neuropsychological deficits 
affecting decision-making in the acute states of BD.  In particular, greater neuropsychological 
dysfunction has been associated with a higher number of manic episodes (for a review see 
Robinson and Ferrier, 2006), which could explain the findings observed in the current review.  
Moreover, abnormalities in thinking patterns have been found to precede behavioural 




manifestations of mania in other studies (e.g., Goldberg et al., 2008), thus these results are of 
high clinical relevance in that risk-taking could be conceptualised as a marker of prodromal 
mania, thus opening an array of possibilities in terms of preventive clinical interventions.   
In regards to depression, studies included in the current review did not find consistent 
evidence for higher risk-taking during depressive states of BD.  Nonetheless, it has to be 
noted that most studies included involved samples of people in euthymic and/or manic states 
of BD, with very limited information available on depressive states.  Holmes et al. (2009) 
involved a sample which comprised predominantly of people in euthymic and depressed 
states of BD, but they found no differences between people with BD and the control group on 
BART performance. 
There is some evidence in research of neuropsychological dysfunction during BD 
depression (Robinson and Ferrier, 2006); a study comparing medicated and un-medicated 
participants experiencing a depressive episode of BD found evidence of altered cognitive 
functioning in medicated BD but not in the un-medicated group, compared to healthy controls 
(Holmes et al., 2008).  Antidepressants have been consistently shown to contribute to 
cognitive impairments, especially when there is prolonged use (for a review see Moraros et 
al., 2017).  Therefore, it can be inferred that neurocognitive dysfunction in BD depression 
could be a result of antidepressant use, particularly in people who experience repeated 
episodes and may require long-term treatment.  Nonetheless, this remains a rarely explored 
topic in research specifically focusing on risk-taking behaviours in BD, thus further studies 
are necessary to support this claim. 
The findings of the current review can also be explained in the context of the 
depression-avoidance hypothesis (Mason et al., 2012), which conceptualises risk-taking as a 
way of responding or trying to prevent negative affectivity in people diagnosed with BD.  
According to this psychological theory, people with BD experience conflicting emotions, 




particularly during the manic states of the condition; for instance, co-occurring euphoria and 
sadness during mania (Cassidy et al., 1998).  This is hypothesised to cause a cognitive 
dissonance, which signals to the brain to resolve the uncomfortable conflict by trying to 
trigger a more positive state (Harmon-Jones and Harmon-Jones, 2007).  Consequently, people 
might engage in risk-taking behaviours, which are intrinsically rewarding and enticing to 
avoid the uncomfortable negative emotion.  This hypothesis has not been formally tested in 
the context of risk-taking in BD.  It would be beneficial to conduct future studies specifically 
focusing on this possible conceptualisation of risk-taking to contribute to the development of 
further psychological therapies, which could target these particular response styles, 
eventually reducing risk-taking behaviours in the BD population. 
It is interesting to note that there seem to be a paucity of research focusing 
specifically on cognitive functioning in people experiencing a depressive episode of BD.  The 
majority of literature on the topic focuses predominantly on euthymic and manic states of 
BD; therefore, more research is necessary to clarify whether risk-taking is present in some 
form during the depressive states of BD and further explore the role of medication. 
4.2.  Predictors of risk-taking 
The current review also aimed at exploring whether there are any reported predictors 
of risk-taking in BD.  Several predictors were identified and will be discussed further.  The 
most widely reported predictor of risk-taking in BD was impulsivity, which was explored in 
four studies (Edge et al., 2013; Hıdıroğlu et al., 2013; Kathleen Holmes et al., 2009; 
Richardson and Garavan, 2010).  Overall higher levels of impulsivity were found to be 
associated with higher risk-taking in BD.  Findings were mixed in regard to the type of 
impulsive behaviour (motor, attentional or non-planning) related to risk taking and further 
research is needed to clarify this point.   




High levels of impulsivity have been consistently reported in participants diagnosed 
with BD, including during euthymic states (for a review see Saddichha and Schuetz, 2014) 
and have also been observed in non-clinical populations at risk of developing BD, suggesting 
that impulsivity could be a possible vulnerability marker for BD (Wessa et al., 2015).  These 
results might help elucidate the mechanisms behind risk-taking behaviours in the BD.  
Nonetheless, research on the topic is still scarce and further studies analysing the links 
between impulsivity and risk-taking in BD, with a focus on differences in mood states, would 
be beneficial to further our understanding of this topic. 
Three studies investigated the links between medication and risk-taking.  Use of 
antipsychotic medication (Reddy et al., 2014) and benzodiazepine (Adida et al., 2011) and 
non-adherence to psychiatric medication were positively correlated with higher rates of risk-
taking behaviours, whilst use of antidepressants was negatively correlated with risk-taking 
behaviours, i.e., participants not using antidepressants were found to have higher rates of 
high-risk behaviours (Adida et al., 2011).  It is worth noting that non-adherence to psychiatric 
medication has been associated with greater symptom severity and lower likelihood to 
achieve remission (Hong et al., 2011), thus it is possible that the higher rates of risk-taking 
are a result of these factors rather than medication in itself. 
There is a debate on whether the cognitive impairments observed in BD are a stable 
trait marker of BD or whether they are dependent on mood episode.  There is some evidence 
in support of the idea that chronic cognitive impairments persist beyond acute mood states of 
BD (Martínez-Arán et al., 2004); however, these studies rarely control for medication effects.  
Considering that a large proportion of people diagnosed with BD are on long-term 
maintenance pharmacotherapy, particularly antipsychotics and antidepressants (Geddes and 
Miklowitz, 2013), clarifying the impact of these on cognitive functioning and thus on risk-
taking is of vital importance for the development of future treatment and therapy approaches. 




The studies included in the current review offer some preliminary evidence to show 
that medication has a significant impact on rates of risk-taking.  Nonetheless, evidence is still 
scarce to draw meaningful conclusions.  Future studies including medication impact in 
regression models are required to offer some clarification on the mechanisms underlying the 
links observed in this review. 
Among other explored factors, suicidal behaviour was found to be predictive of 
higher risk-taking in BD; Martino et al., (2011) found that patients with a history of suicide 
attempts scored worse on IGT than those without a history of suicide attempts.  Nonetheless, 
the authors did not test the direction of the relationship between suicide attempts and IGT 
performance.  The stress-diathesis model suggests that lower performance in decision-making 
tasks is a vulnerability factor for suicidal behaviour (Jollant et al., 2005), thus it is unclear 
whether these two patterns of behaviour occur concurrently or whether one causes the other.  
A recent review by McGirr and Turecki, (2008) found a relationship between impulsivity 
traits and suicidality in clients diagnosed with schizophrenia, thus it would be interesting to 
clarify how these three variables interlink in BD and whether the relationship between 
suicidality and risk-taking might be mediated by impulsivity. 
Finally, one study found lack of insight to be a predictor of IGT performance (Adida 
et al., 2008).  Nonetheless, the links between insight and risk-taking are complex and require 
careful interpretation.  In fact, poor insight has been linked to other clinical variables (e.g., 
duration of illness, mood episode severity), thus it is difficult to comment of whether insight 
might be the result of a general poorer course of illness or whether it is a contributing factor 
to poorer functioning and risk-taking.  Moreover, insight is a difficult construct to measure as 
it is often clinically conceptualised as the client’s level of agreement with their “difficulties”, 
thus based on subjective evaluations rather than an objective measure.  Further studies would 




be helpful to clarify possible nuances in relation to the role of insight in predicting risk-taking 
in BD.   
It would also be beneficial to explore risk-taking behaviours within the context of the 
positive experiences during states of mania reported by people diagnosed with BD, in order 
to clarify whether risk-taking in itself is always a negative outcome, or whether certain types 
of risk-taking behaviours could have a more positive conceptualisation in modern society. 
4.3.  Limitations 
 This review yielded some helpful findings in relation to risk-taking behaviours in BD.  
Nonetheless, some limitations need to be noted.  First, due to the difficulty in measuring risk-
taking in real life situations, this review relied predominantly on studies involving self-report 
measures and laboratory measures (e.g., the IGT and CGT) of risk-taking.  This poses a 
significant challenge in the generalisation of the findings as data from self-reports and 
laboratory settings is predominantly based on self-selecting participant samples with less 
illness severity; therefore, it is difficult to establish whether these samples are representative 
of the general population of people diagnosed with BD. 
 Furthermore, while there is some evidence of external validity of behavioural tasks 
such as the IGT, these tasks are difficult to interpret in terms of underlying processes as task 
performance could be influenced by motivational and cognitive variables that are not directly 
addressed in these measures (Busemeyer and Stout, 2002).  Moreover, there is paucity of 
research investigating correlations between laboratory measures attempting to investigate the 
same construct, e.g. risk taking.  The question of whether the different available tasks are all 
measuring risk-taking still remains unanswered (Buelow and Suhr, 2009); for instance, 
comparisons between the IGT, BART and CGT would be beneficial to help interpret the 
findings yielded in this review.  




Additionally, although some studies included a case-control design, 35% studies 
(n=8) lacked comparisons with a control group, which made it challenging to establish 
causality between the variables identified in individual studies.  This was particularly true for 
studies adopting self-report measures, which found people diagnosed with BD to report a 
variety of risk-taking behaviours.  Nonetheless, it was difficult to conclude whether the 
reported behaviours were general characteristics of a BD diagnosis or whether they were due 
to differences in participant samples.   
It is also important to notice that most studies reported relationships between risk-
taking and other observed constructs, thus it was difficult to comment on causality between 
the different variables.  This was particularly true for studies involving self-report measures 
where participants with BD reported a higher likelihood to engage in certain risk-taking 
behaviours.  Moreover, non-response bias also poses a problem in cross-sectional studies as 
there is no method for testing whether participants opting to take part in the study are 
different from those who do not (Sedgwick, 2015).  This point is particularly relevant for this 
review, where quality assessment identified a general lack of reporting in relation bias, most 
importantly in studies involving self-report measures and opt-in recruitment methods, where 
selection bias was rarely considered. 
 Finally, although some studies reported sub-group analysis, most studies included in 
the current review did not take into consideration the influence of demographic and clinical 
variables on the findings.  This is likely to be a result of small sample sizes, particularly in 
studies involving clinical samples, which may have made it difficult to conduct further sub-
group analyses.   
4.4.  Clinical implications 
The current review had several clinical implications.  First, the findings yielded 
suggest a trend for higher risk-taking behaviours during states of mania in BD and 




(hypo)mania risk in non-clinical populations, which seem to point towards the idea of risk-
taking as a characteristic of a “mania prodrome”.  This is of high clinical relevance as, if risk-
taking can be indicative of prodromal stages of mania, clinicians may wish to adopt 
preventative strategies specifically aimed at utilising Cognitive Behavioural Therapy (CBT) 
techniques to help the clients detect their warning signs by identifying subtle differences in 
thinking patterns, which could in turn help to prevent clients from experiencing an acute 
manic episode.   
 Furthermore, the identification of the role of medication in predicting risk-taking 
behaviours requires some consideration.  At present, the overwhelming majority of people 
diagnosed with BD receive pharmacological treatment both in the acute stages of the 
condition and during periods of remission (National Collaborating Centre for Mental Health, 
2014).  Prescribed medication for BD routinely involves the use of antipsychotics and 
antidepressants, or a combination of both.  The negative consequences of long-term use of 
both antipsychotic (Bentall and Morrison, 2002; Young et al., 2015) and antidepressant (Bet 
et al., 2013; Keefe et al., 2014) medication are widely documented in research.  Side effects 
are one of the reasons reported by people diagnosed with BD for treatment non-adherence 
(Clatworthy et al., 2009), which constitutes a major issue in this population (World Health 
Organization, 2003).  Therefore, the impact of medication on risk-taking behaviours must be 
carefully monitored in clinical practice and these links must be considered by both medical 
professionals and psychologists alike when considering the best approach for treatment and 
therapy.   
Finally, the links between suicidal behaviour and risk-taking are of particular clinical 
relevance; in fact, people diagnosed with BD have higher rates of both suicide attempts and 
completed suicide compared to the non-clinical population (Clements et al., 2013).  BD has 
also been linked to the highest risk of suicide among major psychiatric conditions (Goldstein 




et al., 2012; Redfield Jamison, 2000; Abreu et al., 2009; Goodwin et al., 2007).  
Understanding the relationship between suicidal behaviour and risk-taking could contribute to 
the development of preventative therapies, which specifically target these behaviours to 
improve quality of life and reduce completed suicide rates in BD.  The causal relationship 
between suicidal behaviour and risk-taking remains unclear and it would be beneficial to 
conduct further research to clarify this point to further investigate whether suicidal behaviour 
is a form of risk-taking.  This could help clinicians adopt more appropriate interventions 
targeting risk-taking, which could in turn decrease suicidality. 
5. Conclusions 
Characterising risk-taking behaviour in BD is a challenging task.  Studies on the topic 
show an over-reliance on laboratory and self-report measures, which make it difficult to 
generalise findings to real-life situations.  Results from laboratory studies may be 
complemented by further observational research of clinical samples with BD.  
Findings from the current review suggest that risk-taking behaviours are indeed more 
likely in people diagnosed with BD than controls, but that this might be limited to the manic 
stages of the condition, with participants in euthymic stages of BD showing no differences in 
risk-taking compared to control groups.  Nonetheless, the methodological limitations 
previously identified pose a significant challenge in determining causation, thus any 
generalisation needs to be approached cautiously.  Further longitudinal studies following 
groups of people diagnosed with BD across different states of the condition may offer further 
clarification for the mechanisms behind risk-taking and establish whether clinical factors 
influence this.  However, these studies would involve a baseline measure of risk-taking 
during euthymic states to test any increases/decreases in risk-taking activity during acute 
states of BD, which poses significant challenges as it would be highly demanding for 




participants and researchers alike.  Further studies aimed at capturing real life situations 
might also be helpful to shed light on this topic. 
The current review also found preliminary evidence to suggest that there are some 
factors that predict risk-taking in BD.  Knowledge of these factors has significant clinical 
implications and could contribute to the development of more effective treatments and 
therapies for people diagnosed with BD, who still experience overwhelmingly high rates of 
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Table 1.  Quality Assessment using STROBE score (von Elm et al., 2014) 
Study Strobe Item 
 1a 1b 2 3 4 5 6a 6b 7 8 9 10 11 12a 12b 12c 12d 12e 13a 13b 13c 14a 14b 14c 15 16a 16b 16c 17 18 19 20 21 22 
Adida et 
al. (2008)  
- + + + - + + + + + - + + + + - - - - - - + - NA + - - - + + - + - + 
Adida et 
al. (2011) 
+ + + + - + + + + + - + + + + - - - - - - + - NA + - - - + + + + - + 
Bakare et 
al. (2009) 








- + + - + + + NA + + - + + + - - - - + - - + - NA + + - - + + - - - + 
Devlin et 
al. (2015) 




- + + + - + - - + + - - + + + - - - - - - + - - + - - - + + + + + + 
Edge et 
al. (2013) 
- + + - - + + + + + - + + + + - - - - - - + - NA + - - - + + + + - + 
 




Table 1.  Quality Assessment using STROBE score (continued) 
Study Strobe Item 








- + + + - + + - + + - + + + + - - - + - - + - NA + - - - + + - + + + 
Hariri et 
al. (2011) 




- + + + - + + + + + - + + + + - - - - - - + - NA + + - - + + + + + + 
Holmes et 
al. (2009) 








- + + + - + + + + + - - + + + - - - - - - + - - + - - - + + + + - + 
Meade et 
al. (2008) 
- + + + - - + NA + + - + + + + - - - + - - + - - + + - - + + + + - + 
 




Table 1.  Quality Assessment using STROBE score (continued) 
Study Strobe Item 
 1a 1b 2 3 4 5 6a 6b 7 8 9 10 11 12a 12b 12c 12d 12e 13a 13b 13c 14a 14b 14c 15 16a 16b 16c 17 18 19 20 21 22 
Meade et 
al. (2011) 
+ + + + - + + - + + - + + + + - - - + - - + - - + + - - + + + + + + 
Meade et 
al. (2012) 
- + + + + + + - + + - - + + + - - - - - - + - - + - - - + + + + + + 
Reddy et 
al. (2014) 




- - + - - - - - - + - - - - - - - - - - - + - - - - - - + + + + - - 
Roisier et 
al. (2009) 




- + + + - - - + + + - - + + + - - - - - - - - - + - - - + + - - - - 
Stewart et 
al. (2012) 
- + + + - - + NA + + - + + + + - - - + + + + - - + + - - + + + + + - 
 
 




Table 2.  Studies included in the review 
Author(s) Design Participants Gender distribution Age Mean 
(SD) 
Risk-taking measure Diagnosis/Hypomania 
measure 
Key findings Quality 
Score 






51% M, 49% F 
51% M, 49% F 
37.8 (12.7) 
37.3 (11.5) 
IGT1 DSM-IV BD 
YMRS2 
HDRS3 
Similar performance on the first block between the two groups. In 
the second block, the manic group chose more cards from the risky 
deck. No differences between group taking neuroleptics and those 
who were not. 
IGT performance deficits highly related to lack of insight in the BD 
group. 
66% 








51% M,  
49% F 
44% M, 56% F 
36% M, 64% F 






IGT DSM-IV BD-I 
YMRS 
HDRS 
Manic, depressed and euthymic BD selected more cards from the 
risky decks than healthy controls. No differences observed between 
manic and depressed, depressed and euthymic or manic and 
euthymic. All groups preferred decks offering low-frequency 
penalties over those with high-frequency penalties. 
72% 







63% M, 37% F 16.90 
(1.07) 
Clinical Interview 
for sexual risk 
behaviour4 
DSM-IV BD 46% adolescents with BD had positive history of sexual risk 
behaviour in the past year. Sexual risk behaviour was associated 
with having a comorbid condition, level of religious activities 
(moderate, high level was a protective factor against sexual risk 
behaviour), parents’ marital status (adolescents of single parents 
more likely to engage in sexual risk behaviours). 
45% 
1IGT: Iowa Gambling Task (Bechara et al., 1994); YMRS: Young Mania Rating Scale (Young et al., 1978); HDRS: Hamilton Depression Rating Scale (Hamilton et al., 1960). 4Sexual risk behaviour 
defined as having unprotected sexual intercourse, intercourse with commercial sex workers, sexual intercourse with multiple partners without protection in the past year. 
 
 




Table 2.  Studies included in the review (continued) 
Author(s) Design Participants Gender distribution Age Mean 
(SD) 
Risk-taking measure Diagnosis/Hypomania 
measure 








45% M, 55% F 
55% M, 45% F 
19.2 (.25) 
19.8 (.26) 








When dilemmas were framed positively (in terms of gains) 
compared with negatively (in terms of losses) the shift between risk-
averse and risk-seeking choices was significantly reduced in BD 
participants compared to healthy controls. BD participants did not 
show a general tendency to risk-taking, but instead they showed a 
reduced sensitivity to psychological factors that promote and inhibit 
risky behaviour (framing effects). 
56% 
de Sousa 






69% M, 31% F 
67% M, 33% F 
36.9 (10.9) 
37.5 (10.9) 
AUDIT7 and BSS8 MDQ 
MINI 
BD reported higher rates of sex with commercial partners, sex 
outside the primary relationship, smoking before HIV diagnosis, 
Alcohol Use Disorder before and after HIV diagnosis, illicit drug 
use before and after HIV diagnosis, compared to the non-BD group. 
65% 













HPS11 Hypomania risk was associated with increased expected 
involvement in risk-taking in the next 6 months and it was also 
associated with less tokens earned on the BART, indicative of 
poorer performance on the risk-taking task. Participants with higher 
hypomania risk also anticipated significantly fewer costs to result 
from engaging in risk-taking, but showed no differences in 
appraisals of benefit to result from engaging in risk-taking. 
70% 
1EBD: Euthymic Bipolar Disorder; 2MDQ: Mood Disorder Questionnaire (Hirschfield et al., 2000); 4MINI: Mini International Neuropsychiatric Interview (Sheehan et al., 1998); 4HAM-D: Hamilton 
Depression Rating Scale (Hamilton, 1960); 5YMRS: Young Mania Rating Scale (Young et al., 1968). 6both groups were HIV positive; 7AUDIT: Alcohol Use Disorder Identification Test (Saunders et al., 
1993); 8BSS: Behavioural Surveillance Surveys (Amon et al., 2000). 9CARE: Cognitive Appraisal of Risk Events scale (Fromme et al., 1997); 10BART: Balloon Analogue Risk Task (Lejuez et al., 2002) ; 
11HPS: Hypomania Personality Scale (Eckbald and Chapman, 1986).  
 




Table 2.  Studies included in the review (continued) 






Key findings Quality 
Score 







35% M, 65% F 20.17 CARE – Risky 
Sexual Activity 
Scale1 
WASSUP2 Risk for mania interacted with effortful control to predict risky 
sexual behaviour. When the risk of mania was high, effortful 
control buffered against the likelihood of reporting risky sexual 
events. When the risk of mania was low, effortful control was 
unrelated to the likelihood of risky sexual behaviour. Similarly, for 
number of risky sexual behaviours, at low levels of effortful 
control, risk for mania was positively associated with involvement 
in risky sex, but at high levels of effortful control, risk for mania 
was unrelated to risky sex. Age was related to the likelihood to 
engage in risky sex; older participants were more likely to engage 
in risky sex than younger ones. 
65% 




55 BD-I R3 
39 Control 
35% M, 65% F 
41% M, 59% F 
36 (11.9) 
33.5 (12.8) 
IGT4 DSM-IV BD-I 
BRMS5 
MHRSD6 
There were no significant differences between the BD and control 
group in the IGT performance. BD participants were not found to 
be more likely than controls to select cards from risky decks. There 
was also no significant correlation between demographic variables, 
mood state, illness severity, comorbidity, mood stabilizer use or 
impulsivity and likelihood to select from risky decks in the IGT. 
66% 
CARE: Cognitive Appraisal of Risk Event Scale – Risky Sexual Activity Scale (Fromme et al., 1997); 2Willingly Approached Set of Statistically Unlikely Pursuits (Johnson and Carver, 2006). 3BD-I R: 
Bipolar Disorder Type 1 in Remission; 4IGT: Iowa Gambling Task (Bechara et al., 1994); 5BRMS: Bech-Rafaelson Mania Scale (Bech et al., 1979); 6MHRSD: Modified Hamilton Rating Scale for 









Table 2.  Studies included in the review (continued) 














71% participants reported overspending when hypomanic. 
Participants reported conflict with family members, financial 
hardship and being unable to afford general living expenses as the 
most common consequences of overspending. 68% participants 
reported excessive alcohol consumption when hypomanic. 
Participants also reported being able to consume a larger quantity 
of alcohol than usual when hypomanic. The most common 
consequences of excessive alcohol use were risky sexual 
behaviour, conflict with family/friends/partner, aggressive 
behaviour, socially inappropriate behaviour and experiencing 









48% M, 52% F 
32% M, 68% F 




CCL-M5 DSM-IV BD or MDE 
YMRS6 
HAM-D7 
BD participants scored significantly higher than both MDE and 
Control participants on the Excitement and Risk-Taking subscale 
of the CCL-M. 
68% 
1MINI: Mini International Neuropsychiatric Interview (Sheehan et al., 1998); 2QIDS-SR: Quick Inventory of Depressive Symptoms – Self-Report (Rush et al., 2003). 3Hypomanic/Manic Bipolar Episode; 4Unipolar 











Table 2.  Studies included in the review (continued) 




Key findings Quality 
Score 








36% M, 64% F 
41% M, 59% F 
69% M, 31% F 







DSM-IV BD, SCH, 
HA 
The majority of risky sexual behaviours occurred in the Heroin 
Addict (HA)  group. However, the BD group showed higher rates 
than the HA for unprotected sex (65% BD, 55% HA), but lower 
rates than in the SCH (67%) and Control (77%) groups, which 
showed the highest rates.  The BD group also showed higher rates 
than the SCH and Control groups for having sex with a 
polygamous person (24% BD, 22% SCH, 19% Control). The BD 
group (11%) also reported the highest rates of undesired 










37% M, 63% F 
32% M, 68% F 




BART6 DSM-IV BD 
YMRS6 
HAM-D 217 
Both the BD and BD-R groups had significantly lower adjustment 
scores after the loss of a temporary gain on the BART than the 
HC group. There were no significant differences between the 
group in the number of exploded balloons in the BART. Linear 
regression analysis showed no effects of clinical characteristics 
(e.g. duration of illness, duration of euthymia, number of past 
episodes) on the BART scores. 
75% 
1SCH: Schizophrenia (in remission for 2 months); 2BD: Bipolar Disorder (in remission for 2 months) 3HA: Heroin Addiction (after detox). 4BD-R: Bipolar Disorder First Degree Relatives; 5HC: Healthy Controls; BART: 









Table 2.  Studies included in the review (continued) 













52%M, 48% F 
21% M, 79% F 




BART4 DSM-IV BD 
HAM-D5 
YMRS6 
Between group differences were found in the number of popped 
balloons on the BART. Post-hoc analysis found that the BD-A 
popped significantly more balloons than both the HC and BD-N 
groups. There were no differences between the BD-N and HC 
groups. The BD-A group also did not show learning behaviour, 
pumping the same amount of air when the previous balloon 
popped as when it did not pop. In contrast the BD-N and HC 
groups adjusted their behaviour. There was no effect of mood on 
the BART performance when BD participants were divided into 



















BDW group reported more frequently having been diagnosed two 
or more times with an STI. Repeated STI in BDW was associated 
with earlier age at onset of BD, longer diagnostic delay and higher 
number of (hypo)manic episodes. The BDW group was also 
found to be significantly more likely than the HC group, to have 
had sex with casual sexual partners, non-monogamous sexual 
partners and partners with HIV unknown condition. 
65% 
1BD-A: Bipolar Disorder with a history of alcohol abuse/dependence; 2BD-N: Bipolar Disorder with no history of alcohol abuse/dependence; 3HC: Healthy Controls; 4BART: Balloon Analogue Risk Task (Lejuez et al., 









Table 2.  Studies included in the review (continued) 













39% M, 61% F 
21% M, 79% F 




IGT2 DSM-IV BD 
HAMD3 
YMRS4 
There were no significant differences between the two BD groups 
and healthy controls on IGT performance. Participants with a 
history of suicide attempts scores worse than those without a 
history of suicide attempts on the IGT. 
65% 







46% M, 54% F 39.33 (10.10) RAB6 DSM-IV BD and SUD 39% participants had multiple sexual partners and 69% engaged 
in unprotected sex over the past 6 months. When compared to the 
US adult population rates, the study participants engaged in 
higher rates of sex with multiple partners, sex trading, sex with 
prostitutes and injection drug use. Recent manic episode, lower 
psychiatric severity, and greater drug severity were all significant 
independent predictors of increased HIV risk. 
65% 




61 BD+SUD 59%M, 41%F 38.3 (11.1) RAB DSM-IV Manic or 
Depressive Episode 
76.3% participants had unprotected sex and 23.7% had multiple 
partners. For mania, average weeks of manic episode predicted 
sex risk score, with participants who experienced more mania 
engaging in greater sexual risk. Increases in cocaine use also 
predicted an increase in sexual risk scores. Average weeks of 
depression were not a predictor of RAB scores. 
76% 
1BD-I and BD-II: Euthymic Bipolar Disorder Type I and Type II; 2IGT: Iowa Gambling Task (Bechara et al., 1994); 3HAMD: Hamilton Rating Scale for Depression (Hamilton, 1960); 4YMRS: Young Mania Rating 









Table 2.  Studies included in the review (continued) 




Key findings Quality 
Score 








65% M, 35% F 45.3 (7.1) TLFB3 DSM-IV BD, MDD, 
NMD 
MINI4 
All participants were diagnosed with HIV. Participants in the BD 
group were significantly more likely than the MDD and NMD 
groups to report unprotected sex over the past 3 months. There 
was a significant BDxSUD interaction; the relationships between 
BD and unprotected sex was greater among participants with SUD 
compared to no-SUD. Participants in the BD group were also 
significantly less likely to take their ARV medication than MDD 
and NMD groups. Adherence to ARV was poorer in participants 
who reported unprotected intercourse with HIV-negative partners 
compared to those who did not. Participants who reported greater 
unprotected intercourse with HIV-negative partners and lower 
ARV medication adherence had greater symptoms of mania and 
depression. 
67% 







54% M, 46% F 
55% M, 45% F 









There were significant differences between the schizophrenia 
group and the BD and Control groups on BART performance, but 
no differences between the BD and Control groups. The 
Schizophrenia group showed more risk aversion than the BD and 
Control groups. 
58% 
 1MDD: Major Depressive Disorder; 2NMD: no mood disorder; TLFB: 3Timeline Follow-Back Method (Carey et al., 2001); 4MINI: Mini International Neuropsychiatric Interview (Sheehan et al., 1998). 5SCH: 
Schizophrenia; 6BART: Balloon Analogue Risk Task (Lejuez et al., 2002); 7BPRS: Brief Psychiatric Rating Scale (Ventura et al., 1993); 8HAM-D: Hamilton Depression Rating Scale (Hamilton, 1960); 9YMRS: Young 
Mania Rating Scale (Young et al., 1978). 
 




Table 2.  Studies included in the review (continued) 




Key findings Quality 
Score 
Richardson 







14%M, 86% F 22.26 (6.11) DOSPERT1 HCL-322 There were strong positive correlations between hypomanic 
symptoms and impulsivity and risk-taking. Hypomania scores 
were significantly predicted by total DOSPERT scores, but not by 
the individual subscales of the DOSPERT. Thus, hypomanic 
symptoms were related with a higher propensity to risk-taking in 
general, but not with a particular type of risk-taking. 
Demographic variables influenced this relationship; hypomania 
was associated with ethical risk-taking in participants who were 
younger in age. There was also a stronger relationship between 
the DOSPERT health/safety subscale and higher hypomania 
scores for women compared to men. 
29% 






33% M, 67% F 








The BD group made significantly more commission errors during 
‘sad’ target blocks than ‘happy’ in the AGNG compared to 
controls. The BD group responded more slowly than the HC 
group on the CGT, even after controlling for age. However, there 
were no differences in risk adjustment (the extent to which 
participants altered their betting behaviour based on risk) or 
quality of decision making between the two groups. 
67% 
1DOSPERT: Domain Specific Risk-Taking Scale (Blais and Weber, 2006); 2HCL-32: 32-item Hypomania Checklist (Angst et al., 2005). 3EBD: Euthymic Bipolar Disorder; 4HC: Healthy Controls; 5CGT: Cambridge 
Gambling Task (Rogers et al. 1999); 6AGNG: Affective Go/No Go test (Murphy et al., 1999); 7SCAN: Schedules for the clinical assessment of Neuropsychiatry (Wing et al., 1990); 8BDI: Beck Depression Inventory 
(Beck et al., 1961); 9AMS: Altman Mania Scale (Altman et al., 1997). 
 




Table 2.  Studies included in the review (continued) 



















DSM-IV BD, BPD 
HAM-D3 
YMRS4 
Participants in the BPD group showed less attention to 
prospective losses and gains than both the BD and HC groups. 









32%M, 68% F 







DSM-IV criteria for 
mania or hypomania 
Participants classified in the ESM+ group were significantly more 
likely than those in the ESM- group to have had vaginal or anal 
sex, have two or more partners in the last 90 days, test positive for 
an STI, have unprotected sex and exchange sex for money, drugs 
or shelter. Multiple sexual partners was significantly associated 
with greater impulsivity. 
68% 
1BPD: Borderline Personality Disorder; 2Risky-Choice Task (Rock et al., 2013; Rogers et al., 2003); 3HAM-D: Hamilton Rating Scale for Depression (Hamilton, 1960); 4YMRS: Young Mania Rating Scale (Young et al., 











Table 3. Outcomes for the main three research questions 
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Adida et al. 2008 Yes BD Manic vs Healthy 
Controls 
Lack of insight predicted higher risk-taking Yes – no differences between BD 
group taking medication and BD 
group not taking medication 
Adida et al. 2011 Yes – no differences 
between mood 
states. All BD 
groups had higher 
risk-taking than 
controls 
BD Manic, BD 
Depressed, BD 
Euthymic vs Healthy 
Controls 
Low level of education, high depression ratings (HDRS 
score), use of benzodiazepine, non-use of SNRI 
antidepressants and family history of BD were significant 
predictors of higher risk-taking. 
Yes – use of benzodiazepine and 
SNRI antidepressants were 
significant predictors of IGT scores 
in the BD groups 
Bakare et al. 2009 Yes – however, no 
control group was 
present 
Adolescents with BD Presence of co-morbid disorders, level of religious activities 
and marital status of the parents were significant predictors 
of risk-taking.  Children of single parents were more likely to 
engage in sexual risk-taking.  Moderate/high levels of 
religious activities were protective against risk-taking. 
No 
	





Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Chandler et al. 2009 No Euthymic BD vs 
Healthy Controls 
NA Yes - BD group was medication free 
De Sousa Gurgel et 
al. 2013 
Yes HIV+ BD vs HIV+ 
Controls 
NA No 




Adults from the 
community assessed 
for hypomania 
NA Non-clinical sample – medication-
free 
Dvorak et al. 2013 Yes – only when 
effortful control was 
low and risk for 




Older age and higher sensation seeking were significant 
predictors of a higher likelihood of having engaged in risky 
sexual behaviours in the past 6 months.  After controlling for 
gender, sensation seeking was only significant for men but 
not women.  Effortful control was also protective against 
risk-taking, but only in participants at high risk for mania. 
Non-clinical sample – medication-
free 
	





Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Edge et al. 2013 No BD-I in remission vs 
healthy controls 
No relationship between demographic variables (age, gender, 
education), mood state, illness severity (number of previous 
episodes, number of hospitalisations, number of suicide 
attempts), comorbidity, use of mood stabilisers, impulsivity 
and risk-taking. 
Yes – no effects of mood stabilisers 
on IGT performance 
Fletcher et al. 2013 Yes – self-reported 
higher risk during 
hypomania 
BD-II NA No 
Goldberg et al. 
2005 
Yes – BD had 
higher risk taking 
than both Major 
Depressive Episode 
and Control groups 
BD (hypo)manic vs 
Major Depressive 










Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Hariri et al. 2011 No BD in remission vs 
Schizophrenia, 
Heroin Users and 
Healthy Controls 
NA No 
Hidiroglu et al. 
2013 
No – BD and BD-R 
only had lower 
adjustment scores in 
the BART but no 
evidence of general 
tendency of higher 
risk-taking 
BD vs BD-Relatives 
and Healthy Controls 
Impulsivity correlated with risk-taking.  Higher scores on the 
BIS-Total, BIS-Attentional, BIS-Motor and BIS-Non 
Planning scales correlated with higher number of exploded 
balloons on the BART. 
No significant relationships between duration of illness or 
euthymia, number of previous episodes, number of previous 










Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Holmes et al. 2009 No – only for the 
BD with history of 
alcohol abuse. No 
differences between 
BD with no history 
of alcohol abuse and 
healthy controls 
BD with history of 
alcohol abuse vs BD 
with no history of 
alcohol abuse and 
Healthy Controls 
Higher scores on the BIS-Motor subscales correlated with 
more balloons popped on the BART.  There were no 
correlations between the BIS-Attentional and BIS-Non 
Planning subscales with scores on the BART. 
Yes 
Marengo et al. 2015 Yes – self-reported BD vs Healthy 
Controls 
Earlier age at onset of BD, longer diagnostic delay, higher 
number of (hypo)manic episodes correlated with repeated 
STI.  There were no associations between BD type, history of 
substance abuse, number of depressive episodes, age at first 










Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Martino et al. 2011 No Euthymic BD-I and 
BD-II vs Healthy 
Controls 
History of suicide attempts was a significant predictor of a 
higher likelihood to engage in risk-taking behaviours. 
No 
Meade et al. 2008 Yes Co-occurring BD and 
Substance Use 
Disorder compared 
with US general 
population 
Recent manic episode, lower psychiatric severity, greater 
drug severity were all significant predictors of HIV risk. 
No 
Meade et al. 2011 Yes – higher sexual 
risk in participants 
who reported more 
weeks of mania 
compared to 
depression 
Co-occurring BD and 
Substance Use 
Disorder 
More average weeks of mania and days of cocaine use were 
predictors of higher sexual risk behaviour.  Depression was 









Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Meade et al. 2012 Yes – BD had 
higher risk-taking 




BD vs Major 
Depression and 
Healthy Controls 
Poorer adherence to psychiatric medication, greater 
symptoms of mania and depression and poorer adherence 
with ARV treatment were all predictors of higher likelihood 
of having sex with HIV negative partners. 
Yes – poorer medication adherence 
associated with higher risk-taking 
behaviours 
Reddy et al. 2014 No BD vs Schizophrenia 
and Healthy Controls 
Taking antipsychotic medication was a predictor of lower 
scores on the BART even after controlling for symptom 
severity and history of psychosis. 
Yes – BD taking antipsychotics were 
more risk-averse than those not 
taking antipsychotics 
Richardson et al. 
2010 






students assessed for 
risk of hypomania 
Higher BIS-Attentional and BIS-Motor scores predicted 
higher scores on the HCL-32 Risk-Taking/Irritable subscale.  
Risk taking propensity (measured by DOSPERT Ethical and 
Health-Safety subscales) was a predictor of higher scores on 
HCL-32 Risk-Taking/Irritable subscale. 
Non-clinical sample – medication-
free 
	





Table 3. Outcomes for the main three research questions (continued)	
Study Evidence of higher 
risk taking in BD 
Groups compared Predictors of risk-taking Did the study control for medication 
effects? 
Roisier et al. 2009 No – BD group 
responded slower 
than Healthy 
Controls, but no 
evidence of higher 
risk-taking 
Euthymic BD vs 
Healthy Controls 
NA No 
Saunders et al. 2016 No BD vs Borderline 
Personality Disorder 
and Healthy Controls 
NA Yes – no effect reported 
Stewart et al. 2012 Yes – higher risk of 
mania associated 
with higher sexual 
risk-behaviours 
Adolescents assessed 
for risk of mania 
NA Non-clinical group – medication-free 
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Background: Risk-taking behaviours are common in people diagnosed with Bipolar 
Disorder (BD), and the consequences of these behaviours are numerous, impacting on quality 
of life.  Studies conducted in BD attributed risk-taking to impulsivity and mood fluctuations, 
among other factors such as appraisal and coping styles.  Nonetheless, an innovative theory 
of decision-making (Fuzzy Trace Theory; FTT) hypothesised that risk-taking is a “reasoned” 
action, rather than an impulsive one.  The aims of this study were to characterise a group of 
people with BD based on FTT, and to test whether measures of FTT were predictive of risk-
taking intentions in this population. 
Methods: The study included a sample of 58 participants with a self-reported diagnosis of 
BD, who were asked to complete a series of online questionnaires.  Correlations and 
hierarchical regression models explored the cross sectional relationship between FTT 
measures and risk-taking intentions. 
Results: It was found that some BD clinical characteristics of the sample were associated 
with risk-taking intentions.  There was significant variability on responses to FTT measures 
(verbatim and gist) in the sample included.  Finally, measures of FTT were found to be 
significantly associated with risk-taking intentions in BD and both gist and verbatim scales 
significantly predicted risk-taking intentions (medium effect sizes), after controlling for mood 
and impulsivity. 
Limitations: The main limitations of this study were a self-reported diagnosis of BD, the 
small sample size (n=58), older age group and the online recruitment methods, which could 
limit generalizability of the results. 
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Decision making and risk in people diagnosed with bipolar disorder. 
1. Introduction 
Decision-making has been recognised to improve across the lifespan, in part due to a 
progression in brain development that leads adults away from the risky decisions typical of 
adolescence (Christakou et al., 2013).  Adults are considered better decision-makers than 
adolescents, in particular, in decisions that involve risk (Tymula et al., 2013).   
Dual-process theories of decision-making propose that this complex ability involves two 
different types of information processing mechanisms: one which is intuitive and based on 
the person’s initial reaction or “gut feeling” to the situation and the other, which is more 
rational/computational, based on a careful trade-off of risks and benefits of the decision at 
hand and it is thought to succeed the initial intuitive process (for a review see Evans, 2008).  
These two systems are believed to work on a continuum; nonetheless, the intuitive system is 
usually recognised as more primitive and based on emotions, whilst the rational system is 
believed to be mainly a result of the modern era and it is often perceived as a “rationality 
boost” to intuitive thinking (Slovic et al., 2005).    
 In this modern paradigm, behaviours such as risk-taking have been understood as 
resulting from some sort of “fault” of the analytical thinking system and they have often been 
attributed to inherent traits of the person performing such behaviours (for a review see Evans, 
2008).  Within this framework, emotion plays a central role (Cameron and Leventhal, 2003; 
Chaiken and Trope, 1999; Epstein, 1994; Sloman, 1996), as it has been found to strongly 
influence the ability to engage in analytical thinking, thus generally impacting on decision-
making (Schwarz, 2000).  This observation is particularly relevant for clinical populations, 
such as Bipolar Disorder (BD), where emotion is a key characteristic.   
1.1.Risk-taking in bipolar disorder 




Bipolar disorder encompasses a group of “affective disorders” characterised within 
the diagnostic paradigm by extreme shifts in mood, energy and level of socio-psychological 
functioning (American Psychiatric Association, 2013).  Despite its utility in grouping people 
who report similar experiences, diagnosis has been often subject to one main critique: it 
masks heterogeneity and does not take into account the unique experiences of people who fall 
under a similar diagnostic label (e.g., Philips & Kupfer, 2013).  This critique must be taken 
into account particularly when conducting studies involving people with BD, whose 
diagnosis can be difficult to operationalise due to the heterogeneous nature of BD and its 
characteristic frequent “mood shifts”.  For the purpose of this paper, BD will be 
operationalised according to the Diagnostic and Statistical Manual of Mental Disorders 
criteria (American Psychiatric Association, 2013) as, despite their limitation, they remain the 
most widely used paradigm in research.   
BD is associated with impairments in decision-making abilities, in particular in 
decisions involving risk.  People diagnosed with BD have been found to have a higher 
propensity for risk-taking behaviour than the general population (Chandler et al., 2009), 
which can have overwhelming adverse consequences, impacting on multiple areas of the 
person’s life including their physical safety, social and occupational functioning, finances and 
relationships (Kleinman et al., 2003). 
Research has found people with BD to show impaired scores in tasks involving 
decision-making in both the manic (Adida et al., 2008; Murphy et al., 2001; Rubinsztein et 
al., 2006) and depressed (Murphy et al., 2001; Rubinsztein et al., 2006) states of the 
condition.  There is also evidence showing decision-making abilities to be affected in 
euthymic clients with BD (Chandler et al., 2009).  Nonetheless, studies investigating 
decision-making in euthymic stages of BD yield contrasting results (Adida et al., 2011; 
Murphy et al., 2001).   




  Several psychological and pharmacological interventions have been developed in an 
attempt to address the challenges that people with BD face, in relation to the observed risk-
taking behaviours; nonetheless, their efficacy remains understudied (for a review see 
MacDonald et al., 2016).  Moreover, risk-taking in clinical practice seems to be generally 
approached with interventions that are “reactive” (after the behaviour has occurred) and 
indirect (because risk is considered the manifestation of something else, like a manic mood 
experience) in nature, instead of proactive or preventative.  Thus, it is of utmost importance 
to clarify the processes behind risk-taking in people diagnosed with BD to design 
proactive/preventive interventions. 
Engagement in risk-taking behaviours is currently listed as a symptom of mania 
(American Psychiatric Association, 2013); however, there are no comprehensive 
psychological models that explore the development of these behaviours during different 
mood states, including euthymia.  For example, the “depression avoidance” hypothesis 
(Thomas et al., 2007), posits that risk-taking is a strategy for people diagnosed with BD to 
avoid depression during periods of mania, suggesting that risk-taking is dependent on mood 
state.  Nonetheless, this theory is limited in that it does not offer a comprehensive 
conceptualisation of risk-taking across all the different states of BD, which has been observed 
in research. 
Other studies have attributed risk-taking to a difficulty in regulating the pursuit of 
goals (Johnson, 2005), which is closely linked to impulsivity, a concept that has been 
extensively explored in BD research.  For example, a recent meta-analysis found that people 
diagnosed with BD show elevated scores in the Barratt Impulsivity Scale (BIS-11) compared 
to controls (Saddichha and Schuetz, 2014).  The authors reported that the impairment in 
decision-making observed in BD might be a characteristic of the acute phases of BD, rather 
than a general trait of people diagnosed with BD.  A claim supported by several studies that 




found that, although people with BD often show elevated scores on self-report measures of 
impulsivity (e.g. the BIS-11), they do not consistently show impairments in behavioural tasks 
requiring planning and forethought (Holmes et al., 2009; Lombardo et al., 2012).  Therefore, 
it is possible that the process underlying risk-taking behaviour in BD is more complex than 
hypothesised in the impulsivity literature. 
1.2.Fuzzy trace theory (FTT) as an alternative framework for BD 
An innovative theory of decision-making, Fuzzy Trace Theory (FTT) (Brainerd and 
Kingma, 1984; Brainerd and Reyna, 1992), offered a new conceptualisation of the 
mechanisms behind risk-taking behaviours, which moves away from the traditional 
perspective that risk-taking is a result of impulsivity, towards a different understanding of 
risk-taking as the result of a “reasoned” (but faulty) process.  This theory is promising in 
relation to BD as it could help clarify the contrasting findings reported in the impulsivity 
literature on BD. 
 Historically, dual-processing theories of decision-making have attributed risk-taking 
to an over-reliance on a more intuitive (gist-based) way of processing information (Tymula et 
al., 2013), conceptualising more advanced decision making as the ability to carry out a 
rational process of trade-offs between risks and benefits to select the most optimal choice.  
These ideas have been challenged by FTT, which proposes a counterintuitive argument that 
optimal decision making is based on intuition rather than rationality (Brainerd and Kingma, 
1984; Brainerd and Reyna, 1992). 
 FTT posits that, when people are exposed to a meaningful stimulus in their daily 
lives, they record their experiences by creating verbatim and gist representations that are 
stored in memory (Reyna, 2008, 2004; Reyna and Rivers, 2008).  Verbatim representations 
are mental representations that are recorded as similarly as possible to the original 
experience, thus capturing the information in the exact form it was first presented (i.e., it is 




literal, or verbatim).  Conversely, a gist representation is more qualitative and it captures the 
“bottom line” meaning of the information recorded; it is often subjective, and it is influenced 
by several factors including the person’s emotional state, educational/cultural background 
and their developmental stage (e.g., adulthood vs adolescence) (Reyna and Brainerd, 1995). 
 FTT demonstrates how analytical thinking, rather than intuitive thinking, leads to 
risk-taking behaviours.  For example, in a decision-making task involving unsafe sex, when a 
person is presented with the information that there is a 1% chance of contracting HIV when 
engaging in unprotected sex, adolescents (who have been shown to rely predominantly on 
verbatim-based thinking) are more likely to engage in unprotected sex because they base their 
decision on the idea that 1% is objectively a really low risk.  However, they fail to consider 
that, although objectively 1% is a low risk, 1% means that it only takes once (one infected 
person) for a person to contract HIV through unprotected sex.  Conversely, in gist-based 
thinking the bottom-line meaning is considered, i.e. that it only takes once to contract HIV, 
indicating that unsafe sex is not a good option.   
Therefore, analytical (verbatim) thinking is faulty from the outset as it disregards the 
bottom-line (gist) meaning of the information presented, leading to risky decisions (e.g., 
engaging in unsafe sex), implying the idea of a “reasoned route” to risk-taking.  Risk-taking 
is no longer conceptualised as the product of an impulsive act, but as a “deliberate” action 
based on verbatim thinking (Reyna, 2004).  
1.2.1. FTT and emotion 
 A major difference between FTT and other dual processes approaches is their 
interpretation of emotion in the context of risk-taking.  In fact, whilst traditional dual-system 
approaches link emotion to suboptimal decision-making (hence more risk-taking), FTT 
distinguishes between emotion and intuition (Rivers et al., 2008).  According to FTT, 
emotion is not synonym of poor decision-making; in fact, valence (i.e. a simple evaluation of 




a stimulus as “good or bad” based on an intuitive “gut feeling”), is a necessary component of 
gist and it is helpful in decision-making processes (Chick and Reyna, 2012).  Nonetheless, 
valence is thought to be based on experience.  Therefore, whilst adults, who have acquired 
the necessary experience to trigger a negative “gut feeling”, which will lead them to avoid a 
risky situation (e.g. an unprotected sex), adolescents lack this experience and thus, might 
have acquired a “faulty valenced conception” that unprotected sex is fun.  This causes them 
to fail to consider the risks associated with this, an ability that comes subsequently when 
adolescents experience the negative consequences of unprotected sex (e.g. sexually 
transmitted diseases).  
 The role of arousal in decision-making is also relevant.  Arousal is believed to 
heighten the motivational effects of rewards; thus, in a verbatim-based thinking process, 
where there is a trade-off of risks and benefits, decision-makers are even more likely to take 
risks as they tend to over-estimate the benefits and discount the risks of their decision.  
Interestingly, gist-based thinking was found to not be impacted by arousal, thus explaining 
why less advanced thinkers (e.g., adolescents) are found to be more susceptible to arousal 
than more advanced thinkers (e.g., adults) (Rivers, Reyna, & Mills, 2008). 
 FTT offers an interesting framework to further our understanding of risk-taking 
behaviours in BD.  Clarifying where BD is placed on the continuum between verbatim and 
gist-based thinking could offer an innovative insight into the processes leading to risk-taking 
in this population.  This could potentially complement the idea that risk taking in BD is a 
result of impulsivity or heightened mood, which is often characterised as an intrinsic and 
unchangeable personality trait in people with BD, creating a less stigmatising idea that risk 
taking occurs on a normal continuum between verbatim and gist-based thinking. 
  Moreover, some preliminary findings from FTT show interesting implications for the 
involvement of these concepts in risk reduction programs.  Reyna et al. (2015b) tested a FTT-




informed intervention for the reduction of risk-taking behaviours on a sample of adolescents 
and found it was successful in reducing risk-taking behaviours and that it was more effective 
than another risk-reduction programme based on traditional concepts of risk-taking 
behaviours.  These findings could have promising clinical implications for the development 
of new interventions specifically targeting risk-taking behaviours and treatment non-
adherence in people diagnosed with BD. 
1.3.The current study 
The current study aimed at characterising a group of people who self-reported being 
diagnosed with BD in terms of FTT theory.  To achieve this aim the next steps were followed 
and hypotheses investigated: 
a) Aim 1:we evaluated the links between the clinical characteristics of the 
sample and risk-taking intentions. Research on BD suggests that BD Type 
I, longer duration of BD and a higher number of episodes of BD are 
associated with a worse outcome (for a review see Sanchez-Moreno et al., 
2009).  Moreover, as outlined above, mood (mania in particular) is 
associated with higher risk-taking in BD.  Thus, it was hypothesised that 
people with a diagnosis of BD Type I (compared to Type 2 and other BD 
diagnoses), with an early diagnosis (compared to late), a higher severity of 
illness (operationalized as higher number of episodes) and who were 
currently experiencing a mood episode (both mania or depression) would 
score higher on risk-taking intentions scales (measured by the DOSPERT). 
b) Aim 2: we characterised the patterns of response of the sample on FTT 
measures (i.e. gist and verbatim scales). Based on previous research 
outlined above, it was hypothesised that people diagnosed with BD would 
obtain higher scores on verbatim measures compared to gist, indicating 




higher endorsement of verbatim representations.  
c) Aim 3: we explored the associations between the FTT scales and risk-
taking intentions. Research on FTT reported above suggests that people 
who endorse verbatim representations (compared to gist) are more likely to 
engage in risk-taking behaviours.  Therefore, it was hypothesised that there 
would be a positive correlation between verbatim scales and risk-taking 
intentions scales and a negative correlation between gist scales and risk-
taking intentions scales.  
d) Aim 4: we investigated whether FTT scales predict risk-taking intentions 
after accounting for mood state and impulsivity.  Impulsivity and mood are 
well established predictors of risk-taking in research involving people 
diagnosed with BD.  Nonetheless, research on FTT suggests that risk-
taking is not purely a result of higher impulsivity or emotion.  Therefore, it 
was hypothesised that FTT scales would be significant predictors of risk-
taking intentions in people diagnosed with BD even after accounting for 
mood and impulsivity. 
Studies of decision-making in clinical populations are of immense value, because they 
can help to clarify the nature of suboptimal processes in a clinical population, in order to 
establish brain-behaviour relationships and point towards the development of potential 
treatments for BD.  By characterising BD using FTT, it is aimed to offer a clearer framework 
to conceptualise decision making and risk-taking behaviours in people diagnosed with BD, as 
well as offer clinical recommendations to improve outcome in BD.  
2. Materials and Methods 
A total of 110 participants were recruited using social media (Twitter), UK and 
international charities, and client support organisations.  Only 58 participants (53%) 




completed the study.  The research inclusion criteria required participants to be over the age 
of 18, be fluent English speakers, able to provide informed consent and self-reported having a 
diagnosis of bipolar disorder.  Demographic information is available in Table 1. 
2.1.Measures 
 Data were collected through anonymised online questionnaires using Qualtrics 
software (2005), Version 3.5.0, Copyright © [2017].  Demographic (age, gender, current 
employment, level of education, ethnicity and marital status) and clinical (time since 
diagnosis, diagnosis type, number of previous episodes of BD, information about current 
psychological therapy and type, and current medication and type, current mood state, other 
mental health diagnoses) variables were gathered using individual items.   
2.1.1. Fuzzy Trace Theory Scales  
Verbatim scales.  Two verbatim scales introduced by Mills, Reyna and Estrada (2008) 
were used for the current study.  The first scale, a Specific-Risk scale, comprised of 5 items 
that listed concrete consequences of risky sexual behaviour (e.g., contracting HIV or sexually 
transmitted diseases) and asked participants to estimate the personal risk of those 
consequences on a 5-point scale ranging from strongly disagree to strongly agree.  These 
items were designed to trigger verbatim memories of past behaviours (e.g., instances where 
the person engaged in unprotected sex), thus involving a verbatim (or analytic) mode of 
thinking.  The scale showed excellent reliability (α=.96); details are available in Table 2.  A 
second verbatim scale, the Quantitative Risk Scale, asking participants to quantify their risk 
of having an STD on a scale from 0 to 100 was also used as a validity check.  High scores on 
the specific risk and quantitative risk scales indicate endorsement of verbatim principles. 
 Gist scales.  Three gist scales were used to measure gist-based thinking (Mills et al., 
2008).  The Categorical Risk Scale comprised of 9 items that measured categorical thinking 
about risk (e.g., “even low risks happen to someone”), and were rated on a 5-point scale 




ranging from strongly disagree to strongly agree.  High scores on the categorical risk scale 
indicate higher categorical thinking about risk.  The scale showed acceptable reliability 
(α=.79); information is available in Table 2.  The Gist Principles Scale contained 15 simple 
statements about risk (e.g., avoid risk) and participants were asked to indicate which 
statements applied to them (or not).  High scores on the gist principles scale indicate lack of 
endorsement of gist principles.  The scale showed good reliability (α=.80).  Details are 
available in Table 2.  The final gist scale, Global Risk, asked participants to state their 
personal risk of having sex as “low”, “medium” or “high”.  High scores on the global risk 
question indicate high personal risk perception. 
2.1.2. Measurement of mood 
Participants’ manic symptoms were evaluated using the Mood Disorder Questionnaire 
(MDQ; Hirschfeld et al., 2000), and mood was assessed with the 7up 7down inventory 
(Youngstrom et al., 2013).  The MDQ is a 5-item self-report questionnaire, which has been 
developed as a screening tool for bipolar disorder.  Participants are asked to answer ‘yes’ or 
‘no’ to a series of questions about lifetime symptoms of mania and hypomania and 
subsequently indicate the degree of impairment caused by these symptoms.  The 
questionnaire also asks about the participants’ blood relatives’ history of bipolar disorder and 
whether the participants have ever received a diagnosis of bipolar disorder.  In order to obtain 
a positive screen, the following criteria must be met: a positive score (‘yes’) on 7 out of 13 
items of the main questionnaire; a positive response (‘yes’) to question 2 (‘if you checked yes 
to any of the above, have several of these ever happened during the same period of time’); a 
‘moderate’ or ‘serious’ response to question 3 (‘how much of a problem did any of these 
cause you’).  The scale showed acceptable reliability in our sample (α=.71); details are 
available in Table 2. 




The 7up 7down inventory is a measure carved from the General Behaviour Inventory 
(GBI).  It comprises seven items asking about symptoms of mania (7up) and seven items 
asking about depressive symptoms (7down).  Participants are asked to state how often they 
have experienced each symptom during the past two weeks and score each item on a scale of 
never or hardly ever, sometimes, often, very often or almost constantly (scored 0 to 3).  Both 
the 7up (α=.93) and 7down (α=96) scales showed excellent reliability in our sample.  
Information is available in Table 2. 
2.1.3. Measurement of impulsivity 
 Impulsivity was measured using the simplified version of the Barratt Impulsiveness 
Scale (BIS-11; Spinella, 2007).  The BIS-11 simplified is a widely used measure of 
impulsiveness and comprises 14 items scored on a 4-point scale of rarely/never, occasionally, 
often and almost always/always (scored 1 to 4).  The scale showed excellent reliability 
(α=.90) in our sample.  Information is available in Table 2. 
2.1.4. Measurement of risk-taking intentions 
Information about participants’ risk-taking intentions was collected using the Domain 
Specific Risk Taking Scale for Adult Population (DOSPERT; Blais & Weber, 2006).  The 
DOSPERT encompasses two subscales measuring risk taking behaviour (RT) and risk 
perception (RP).  Each scale comprises 30 items.  The RT subscale was used for the current 
study.  The scale is scored using a 7-point scale from “extremely unlikely” to “extremely 
likely” (scored 1 to 7) and asks the participants to score their likelihood to engage in each 
stated behaviour or activity.  The DOSPERT_RT scale comprise of 5 further subscales, each 
comprising 6 items and evaluating risk-taking intentions in different domains: ethical 
(α=.65), financial (α=.77), health/safety (α=.72), recreational (α=.86) and social (α=.77).  A 
further subscale was also computed for the current study and it comprised of items 9 (“having 
an affair with a married man/woman”) and 15 (“engaging in unprotected sex”) of the 




DOSPERT specifically asking about sexual-risk intentions (α=.62).  All subscales showed 
good and acceptable reliability in our sample.  Information is available in Table 2. 
2.2.Data Analyses 
Data were analysed using SPSS version 22.0.  To determine internal consistency of 
the scales utilised in the study, Cronbach’s alpha was calculated.  Descriptive and frequency 
analyses were conducted and correlation and partial correlations analyses were used to 
explore the links between clinical variables and risk-taking intentions. 
Subsequently, participants’ response patterns on the gist and verbatim scales were 
evaluated via exploratory analyses, using measures of central tendency and graphical visual 
inspections, to characterise BD in terms of endorsement of gist and verbatim principles.  
Following this stage, correlation analyses between FTT scales and between FTT with 
DOSPERT Risk-Taking subscales were used to explore the links between endorsement of 
verbatim/gist principles and risk-taking intentions.  Finally, hierarchical regression models 
were conducted to explore whether FTT scales predicted risk-taking intentions after 
controlling for mood and impulsivity.     
2.3.Ethical Statement 
The current study was approved by the Faculty of Health and Medicine Research Ethics 
Committee (FHMREC Reference: C15136) at Lancaster University. 
3. Results 
3.1.Participants’ Characteristics 
A total of 110 participants accessed the online link to the survey used in the study.  
Among these, 58 participants (52%) fully completed the study and were included for 
analysis.  When comparing final sample with participants who did not complete the study, 
but provided demographic information (n=20), no significant differences between groups 




were observed for example on age (t(76)=-1.55, p=.12), gender (x2(2)=3.50, p=.17),  and 
education level (x2(1)=3.46, p=.06) (more details upon request). 
 Demographic and clinical characteristics of the sample are presented in Table 1.  The 
mean age of those with complete data was 49 (SD=15; range 21-78); of these, 68% were 
female (n=39). Eighty-six percent were native English speakers, 72% reported being either in 
employment or students, and 85% reported having completed some form of higher education 
(undergraduate, masters or PhD/Doctorate degree).  Thirty-three percent participants self-
disclosed having received a diagnosis of BD Type I, 46% of BD Type II, 19% of BD Not 
Otherwise Specified and 2% of Schizoaffective Disorder.  Only 5% received these diagnoses 
in the year prior to the study, and 26% were diagnosed more than 16 years ago. Twenty-three 
percent reported having a co-morbid MH diagnosis in addition to BD.  The majority (83%) 
were currently on psychotropic medication for BD, whilst only 40% reported receiving 
psychological therapy.  Thirty-five percent self-reported that they were currently 
experiencing a mood episode, whilst 24%, reported having experienced their last BD episode 
more than 6 months ago. 
In terms of MDQ scores, 53 participants (91%) obtained a positive screening on the 
MDQ, derived from a score of 7 or higher on the first 13 items, a ‘yes’ score on question 2 
and a ‘moderate’ or ‘serious’ response on question 3.  Only 5 (9%) participants obtained a 
negative screening on the MDQ.   
3.2.Data screening and preparation 
Response patterns were screened to check for assumptions of normality.  Categorical 
Risk and the Gist Principles scales showed relatively normal distributions (Table 3).  
Conversely, scores on the Global Risk Question were not normally distributed, showing a 
trend towards lower scores.  In terms of verbatim scales, they also showed a non-normal 




distribution with the same trend towards lower scores for both the Specific Risk Scale and the 
Quantitative Risk Scale.  Details are available in Figures 1 to 6 and Table 3. 
In terms of sample responses to DOSPERT Risk-Taking subscales, all showed a fairly 
normal distribution.  Similarly, scores on the BIS were normally distributed.  Conversely, 
scores on the 7up and 7down scales showed a non-normal distribution with a trend towards 
lower scores.  Details are available in Table 3. 
After exploring cases showing extreme scores (potential univariate outliers), two 
participants were identified reporting the maximum score possible on the Specific Risk Scale 
(an unusually higher score when compared with rest of the sample).  Based on this finding, 
the potential influence of these participants was evaluated when this scale was included in 
our analyses. 
3.3.Aim 1: Associations between bipolar clinical characteristics and Risk-Taking 
intentions 
  Associations between BD clinical characteristics and risk-taking intentions are 
presented in Table 4.  When testing the association of diagnosis type (Bipolar Type I vs. 
Else) with risk taking intentions, it was found that people in the BD I group had lower scores 
than participants with other BD diagnoses (BD-Type II, BD NOS, Schizoaffective Disorder) 
on the DOSPERT Sex subscale (r=.28).   
When assessing the association of early (diagnosed more than 6 years ago) vs. late 
onset (diagnosed less than 6 years ago) with risk intentions scales, after controlling for age 
(correlation of age with early onset vs late was r=.48), non-significant correlations were 
observed.  However, being older was significantly associated with a reduction on intentions 
to engage in risk on Financial (r=-.29), Recreational (r=-.33) and Social subscales (r=-.28). 
Current experience of a mood episode (irrespective of valence, manic or depressive) 
showed significant positive correlations with higher scores on the Financial subscale (r=.35).  




Finally, higher severity of illness (≥ 10 previous mood episodes in the past) was positively 
correlated with risk-taking intentions in health/safety (r=.27) and recreational (r=.32) 
domains, after controlling for age.  
3.4.Aim 2: Response pattern on gist and verbatim scales 
 In terms of response on verbatim scales (Specific Risk and Quantitative Risk scales), 
after excluding the two outliers mentioned above, the Specific Risk (M=7.10, SD=4.08, 
observed range=5 to 25) and Quantitative Risk scales (M=.97, SD=2.16, observed range=0 to 
10) showed a trend towards low scores, indicating lack of endorsement of verbatim 
principles.  
 Regarding measures of gist, 77% scored ‘low’, 18% scored ‘medium’ and 5% scored 
‘high’ on the Global Risk Question, indicating a general low perception of personal risk of 
having sex.  Scores on both the Categorical Risk (M=24.78, SD=5.89, observed range=4 to 
36) and Gist Principles Scales (M=20.93, SD=3.20, observed range=15 - 28) showed more 
variability than in the previous scales.   
3.4.1. Correlations between FTT scales.   
When testing the correlations between the individual FTT scales there were 
significant negative correlations between the Categorical Risk Scale and the Specific Risk 
Scale (rs=-.27), positive correlations between the Gist Principles Scale and the Global Risk 
Question (rs=.29) and the Quantitative Risk Question (rs=.35), a significant positive 
correlation between the Global Risk Question and the Quantitative Risk Question (rs= .29), a 
significant positive correlation between the Specific Risk Scale and the Quantitative Risk 
Question (rs=.53).  No significant correlations were observed between the Gist Principles 
Scale and the Specific Risk Scale (verbatim) (Table 5). 
3.5.Aim 3: Correlations between FTT scales and risk-taking intentions 




 To test whether endorsement of verbatim or gist were related to risk-taking intentions, 
correlation analyses were performed.  In terms of verbatim scales, as aforementioned, it was 
noted that two participants obtained unusually high scores on the Specific Risk Scale, thus 
they were removed from correlation analyses for the Specific Risk Scale but not for the other 
scales. 
In terms of verbatim scales, there were significant correlations between Specific Risk 
Scale and the DOSPERT Ethical (rs=.26, p<.05), Financial (rs=.29, p<.05), Health/Safety 
(rs=.46, p<.01) and Sex (rs=.44, p<.01) subscales.  This indicates that endorsement of 
verbatim principles was related to higher risk-taking intentions in the explored domains.  The 
Quantitative Risk Scale showed significant positive correlations with the Ethical (rs=.44), 
Financial (rs=.49), Health/Safety (rs=.40) and Sex (rs=.48) subscales, also implying that 
endorsement of verbatim principles was linked with higher risk-taking intentions in the 
observed domains (Table 6). 
 Regarding gist measures, the Categorical Risk Scale was not significantly correlated 
with any of the risk-taking intentions scales.  However, the Gist Principles Scale showed 
significant positive correlations with Ethical (r=.40), Health/Safety (r=.36) and Sex (r=.49) 
subscales.  High scores on the Gist Principles Scale indicate low endorsement of gist 
principles.  Therefore, the results indicate that endorsement of gist principles was protective 
against risk-taking intentions in the Ethical, Health/Safety and Sex domains.  Finally, the 
Global Risk Scale was positively correlated with the Financial (rs=.31) and Sex Subscales 
(rs=.42).  High scores on the Global Risk Scale indicate high perception of personal risk, thus 
the results show that higher perception of personal sexual risk is related with higher sexual 
risk-taking intentions (Table 6).  
3.6.Aim 4: Does FTT predict risk-taking intentions after controlling for mood and 
impulsivity? 




 To test whether FTT scales were predictive of risk-taking intentions after controlling 
for mood and impulsivity, FTT scales that were found to be significantly correlated with 
DOSPERT subscales were entered together into a hierarchical multiple regression model.  
Mood and impulsivity were entered separately into the regression model.  First, mood was 
included in Step 1 of the regression model followed by the addition of the FTT scales in Step 
2.  Subsequently, impulsivity was added in Step 1 of the regression model (substituting 
mood), followed by the addition of the FTT scales in Step 2.  
 When predicting intentions to engage in risk-taking related with sex, both the Gist 
Principles Scale and the Specific Risk Scale made significant contributions (part=.31 and 
part=.22) to the model, after controlling for mood, where the (hypo)manic scale (7up) also 
made a significant contribution (part=.27) (Table 7).  The pattern of results was similar when 
impulsivity (BIS Total Score) was added to the model, replacing mood.  However, 
impulsivity was not a significant predictor of risk-taking intentions in the sexual domain 
when FTT scales were entered the model. FTT scales added 27% of variance over and above 
impulsivity (Table 8).  
 When predicting risk-taking intentions in the ethical domain, only the Gist Principles 
Scale (part=.25) and (hypo)mania (7up; part=.27) were found to be significant predictors 
(Table 9).  The same pattern was observed when impulsivity was added to the model, 
replacing mood; the Gist Principles Scale predicted a significant amount of variance 
(part=.29) and impulsivity also made a significant contribution to the model (part=.42) 
(Table 10). 
 Finally, when predicting risk-taking intentions in the health/safety domains, the 
opposite pattern was observed.  In this model, only the Specific Risk Scale made a significant 
contribution (part=.24) instead of the Gist Principles Scale and the depression scale (7down; 
part=.25) instead of the (hypo)mania scale (7up) significantly contributed to the variance 




(Table 11).  In the model that included impulsivity instead of mood, impulsivity was the 
strongest predictor (part=.42), followed by the Gist Principles Scale (part=.24) and the 
Specific Risk Scale (part=.21), which almost reached significance (p=.05).  
 All these models were statistically significant, showing significant predictors small or 
medium effect sizes in the expected direction when predicting intentions to engage in risk 
behaviours.  Effect sizes were calculated using Pearson’s r, where .10<r<.30 is a small effect 
size, .30<r<.50 is a medium effect size and r≥.50 is a large effect size (Ferguson, 2009). 
4. Discussion 
 The current study characterised a group of people diagnosed with BD in terms of FTT 
theory.  First, the links between clinical characteristics of the sample and risk-taking 
intentions were explored.  Second, the patterns of response of the sample on FTT scales was 
investigated.  Third, the associations between FTT measures and risk-taking intentions were 
tested.  Finally, it was investigated whether endorsement of verbatim or gist principles 
predicts risk-taking intentions in different domains.  The findings were promising in that gist 
and verbatim measures explained unique variance in risk-taking intentions that went beyond 
the effects of impulsivity and mood.  However, due to the small sample size and other 
limitations that will be discussed in detail later in the paper, results must be interpreted 
cautiously.   
4.1.BD Clinical Characteristics and Risk-Taking Intentions 
Before proceeding to comment on the main results of the study, it is important to 
outline some information about the characteristics of the participants included.  The sample 
of the current study was varied in terms of BD diagnosis type and experiences related to BD 
(e.g. duration of BD, number of episodes), which reflects the heterogeneous nature of BD.  
Nonetheless, it can be noted that most participants were females and of an older age group.  
Similarly, most participants reported being in some form of employment (or students) and 




having completed higher education, which is somewhat unrepresentative of people with BD 
in general (Hilty et al., 2006; Zimmerman et al., 2010).  These characteristics must be held in 
mind when generalising the findings of the current study. 
 In relation to the first step to explore the links between participants’ clinical 
characteristics and risk-taking intentions, having a diagnosis of BD Type I was associated 
with lower risk-taking intentions in the sex domain (a small effect size), whilst currently 
experiencing a mood episode was related with higher risk-taking intentions in the financial 
domain (medium effect size).  Finally, a proxy of severity of illness (having had 10 or more 
episodes of BD) correlated with higher rates of risk-taking intentions in the health/safety and 
recreational domains (small and medium effects respectively).  
 The finding that a self-report diagnosis of BD Type I was associated with lower risk-
taking in the sex domain was counterintuitive.  However, further analyses are required to see 
if this association persists after controlling for potential confounders such as current mood 
state or treatment status. For example, people with a BD Type I diagnosis are generally 
exposed to more aggressive pharmacological treatments than other forms of BD (National 
Institute for Health and Care Excellence, 2011), that could in part explain this finding.   
 Another interesting finding of the current study was the relationship between mood 
episode and financial risk-taking.  It was found that currently experiencing a mood episode 
positively correlated with higher risk-taking intentions in the current sample, highlighting the 
fact that higher rates of risk-taking intentions in BD could be linked to the effects of mood 
instead of BD diagnosis in general.  Unfortunately, information about the valence of mood 
episode was not available, thus it was not possible to test whether the effects of current mood 
episode on risk-taking were related with manic, depressive or mixed episodes.  Studies 
exploring risk-taking in BD have found consistent evidence of higher rates of risk-taking 
behaviours during the manic states of BD (Adida et al., 2011, 2008).  Nevertheless, the 




relationship between depressive episodes and risk-taking in BD is less clear with studies on 
the topic yielding contrasting results (e.g., Adida et al., 2008; Robinson and Ferrier, 2006).  It 
would be beneficial to conduct further research to investigate this point further.  Future 
studies may wish to compare the BD group with non-clinical groups experiencing sub-
syndromal (hypo)mania and depression to clarify the nuances in relation to these patterns of 
behaviour.  
Finally, it was found that severity of illness (having had 10 or more episodes of BD) 
correlated with higher rates of risk-taking intentions in the health/safety and recreational 
domains.  Research in the field of BD showed that a higher number of episodes is related to 
worse outcome (Di Marzo et al., 2006).  Therefore, it is difficult to further expand on the 
relationship between severity of illness and risk-taking as this could be due to a variety of 
factors linked to a longer and more severe course of BD.  
4.2.Characterising BD and risk-taking with FTT measures 
 One of the main aims of the current research was to explore where BD is placed on 
the continuum between verbatim and gist.  It was hypothesised that people with BD would 
show an over-reliance on verbatim rather than gist representations.  Nonetheless, results did 
not support our hypothesis considering the general pattern of lack of endorsement of verbatim 
principles scales in our sample.  However, it is important to note that the sample included in 
the current study comprised mostly people from an older age group (with a mean age of 49 
years).  Older age is hypothesised to be associated with reliance on gist over verbatim 
representations (Reyna and Brainerd, 1995; Reyna and Farley, 2006) and thus, this fact must 
be considered when interpreting these findings. 
 Interestingly, the pattern of responses on gist scales was varied, showing that non-
endorsement of verbatim principles was not directly related to endorsement of gist principles.  
Moreover, the current study also found no significant correlations between the gist and 




verbatim scales.  These findings are in line with research on FTT hypothesising that verbatim 
and gist representations are encoded simultaneously, but retrieved separately, depending on 
the stimuli presented (Rivers et al., 2008).  Thus, people can have distinct (even 
contradictory) representations of the same situation, but will rely on verbatim of gist 
depending on a series of factors (e.g. age or stimuli).   
In terms of the association between FTT and risk-taking, it was found that FTT scales 
correlated with risk-taking intentions in the expected direction.  Namely, endorsement of 
verbatim principles (although not common) was positively correlated with higher risk-taking 
intentions on the ethical, financial, health/safety and sexual domains.  Conversely, 
endorsement of gist principles was correlated with lower risk-taking intentions in the ethical, 
health/safety and sexual domains.  Finally, there were no significant correlations between the 
Categorical Risk Scale and any of the measures of risk-taking intentions.  These findings are 
partially consistent with other studies in the field, which found contrasting patterns for 
verbatim and gist measures in relation to risk-taking (e.g., Mills et al., 2008).   
The current study also found a counterintuitive result when evaluating the association 
of Global Risk Question and risk; in fact, high scores on this scale were found to be 
positively correlated with risk-taking intentions in the sexual domain, contrary to findings 
reported by by Mills et al., (2008), who found negative correlations between the two 
variables.  FTT suggests that people who are more likely to take risks are prone to deny 
vulnerability when a “global measure” is used, but can acknowledge their risks when cued to 
recall specific events in which they engaged in risk-taking behaviours.  Conversely, risk-
avoiders would be able to acknowledge their global risk of having sex but tend to score lower 
on measures asking for specific risk-taking as they have less events to recall (Reyna et al., 
2015b; Reyna and Brainerd, 1995).  Finally, as aforementioned, the current study found no 




associations between the Categorical Risk Scale and risk-taking intentions.  Further research 
is needed to clarify this point.  
4.3.Do FTT measures predict risk-taking intentions? 
The main findings of the current study were related to the unique predictive value of 
the verbatim (Specific Risk Scale and Quantitative Risk Scale) and gist scales (Gist 
Principles Scale, Categorical Risk Scale and Global Risk Question) when predicting risk-
taking intentions after controlling for mood or impulsivity.  The results showed that, even 
after controlling for mood and impulsivity, which are considered cardinal variables when 
explaining risk-taking in numerous studies (e.g., Hıdıroğlu et al., 2013; Reddy et al., 2014), 
endorsement of verbatim and gist principles explained a statistically significant amount of the 
variance (medium effect sizes) in risk-taking intentions in the sample.  This was in the 
expected direction, supporting our main hypothesis that risk-taking is not simply a result of 
the impulsive behaviour or mood fluctuations typical of BD, but a combination of more 
complex processes involved in decision-making situations (Mills et al., 2008; Reyna, 2008; 
Reyna and Brainerd, 1991). 
There were some subtle differences about predictors when explaining variance on 
different domains of risk-taking intentions, which need to be replicated in future studies.  Of 
relevance was the fact that the process triggered by stimuli related with sex (item content of 
FTT scales) was also capable of predicting risk-taking intentions in other domains such as 
ethical and health/safety.   
Significant differences in predictors of risk-taking intentions across different domains 
have been observed in previous research (e.g., Blais and Weber, 2006), suggesting that the 
processes underlying risk-taking intentions in specific domains might be different.  These 
findings might help explain the different patterns of predictors found in our sample, with gist 
(but not verbatim) predicting risk-taking intentions in the ethical domain, and verbatim (but 




not gist) predicting risk-taking intentions in the health/safety domains.  For example, ethical 
decisions have been hypothesised to be fundamentally different from other types of decisions, 
in that they involve decisions that may directly benefit or harm others (Crossan et al., 2013).  
As such, decisions in the ethical domain are usually based on the person’s internal “ethical 
code”, and have been found to be overwhelmingly dominated by “intuition” rather than 
“rationality” (Rand et al., 2014) thus relying on gist representations rather than verbatim.  
People might have internalised certain situations as “bad” or “good”, deriving the bottom line 
meaning from their experiences.  
Conversely, decisions concerning health/safety are usually based on precise 
information – e.g. risk percentages when trying to consider the lifetime prevalence of a health 
condition – and thus are more likely to cue verbatim representations when the person is faced 
with a decision (Reyna, 2008), supporting our finding that verbatim-based processes (not 
gist) predicted health/safety risk intentions.  However, these finding requires further testing. 
4.4.Clinical implications 
The results of the current study have clinical implications for the management of risk-
taking in people diagnosed with BD.  Nonetheless, due to the small sample size and other 
limitations that will be further explored below, any attempt at generalising the findings must 
be approached with caution. 
The idea of a “reasoned route” to risk-taking in BD is of high clinical relevance; in 
fact, moving away from the idea that risk-taking is an impulsive act, clinicians may wish to 
consider preventative approaches aimed at modifying whether the person relies on 
verbatim/gist representations during decision-making.  Research on FTT has found promising 
results in relation to the applications of this theoretical framework to practical interventions 
for risk-reduction in the adolescent population (Reyna and Adam, 2003; Reyna and Mills, 
2014).   




Most importantly, our findings might help explain why current interventions to 
prevent risk-taking in BD are often proven ineffective.  In fact, risk-prevention programs are 
usually based on the idea that by providing the client with detailed information about the 
risks and benefits of their behaviours, they will be more likely to avoid risky choices.  
Nonetheless, we have observed how this approach is based on the idea that optimal decision-
making is a result of a careful trade-off of risks and benefits, which has been hypothesised to 
cause opposite effects (i.e. more risk-taking) in FTT (Mills et al., 2008; Reyna and Adam, 
2003; Reyna and Farley, 2006).  In fact, it has been found that, when relying on verbatim-
based thinking, although people may be able to correctly recall the specific facts related to a 
situation, they still fail to derive the bottom-line meaning of the situation presented to them, 
which is key to informed decision-making (Reyna, 2008).  Thus, clinicians may wish to 
consider new ideas promoted by FTT to inform a re-evaluation of current preventative 
programs for people diagnosed with BD.  
It is also important to note that gist-based thinking has been shown to be protective 
against risk-taking, not only in laboratory tasks but also in real life decisions, even in 
populations that are usually characterised as “risk-takers”.  For instance, a study found that 
adolescents who perceive risk qualitatively (based on the bottom line, or gist meaning of the 
situation) are less likely to engage in risk-taking behaviours than adolescents engaging in a 
verbatim-based process of trade-off between risks and rewards (e.g., Reyna and Farley, 
2006).  One of the main critiques of studies focusing on impulsivity and mood is that the 
measures used have little generalizability as they are only applicable to laboratory settings 
(e.g., Buelow and Suhr, 2009).  Considering the direct link between gist processing and 
decision-making in real-life situations, our findings may be generalizable to both real-life and 
clinical scenarios.  However, further observational research may be helpful to test this claim. 
4.5.Limitations 




 The results of the current study must be interpreted within its limitations.  First, it is 
important to note that due to the recruitment methods through online means, the current study 
might have a bias toward a group of people that was relatively high functioning and might 
have missed potential participants who were toward the lower functioning end of the 
spectrum.  However, some preliminary analyses comparing participants who completed the 
study and those who did not showed non-significant differences on a series of variables (e.g., 
age, diagnosis type, level of education).   
It is also important to outline that the available clinical information (including BD 
diagnosis) was self-reported by the participants; thus, there was no objective evidence to 
confirm diagnosis of BD and other clinical variables.  In particular, in relation to the self-
reported diagnosis of BD, it is important to acknowledge that this might have impacted on the 
validity of the results.  Nonetheless, due to funding and study design restrictions it was 
difficult to employ a different method to validate BD diagnosis.  Future studies may wish to 
utilise valid diagnostic measures (e.g. the MINI – International Neuropsychiatric 
Interview)(Sheehan et al., 1998) to address this potential issue. 
 Furthermore, due to the relatively small number of participants, the number of 
variables entered into the regression models was limited to ensure statistical power.  This 
made it difficult to explore the effects of clinical and demographic variables on the predictive 
value of FTT scales regarding risk-taking intentions.  It would be beneficial to conduct 
further larger scale studies to clarify this point.   
 It also has to be noted that a large number of statistical comparisons were conducted 
to test the hypotheses of the current study.  This, in addition to the small number of 
participants included in the study, might have increased the chances of Type 1 error.  
Nonetheless, it was decided not to perform adjustment to the data set (e.g. Bonferroni 
correction) as this was an exploratory study to characterise a clinical population utilising a 




new measure (FTT scales) and generate hypotheses, which could have been compromised 
when adopting more stringent criteria of statistical significance.  Future studies may wish to 
address this potential issue by recruiting a larger sample in order to increase statistical power 
and reduce the chances of Type 1 error.    
 Another potential limitation of the current study was the lack of a control group.  
Nonetheless, the recruitment of a control group was beyond the scope of the current study, 
which aimed at providing an initial characterisation of people with a self-reported diagnosis 
of BD according to FTT measures.  Future larger scales studies are necessary to explore how 
this clinical population compares to a healthy control group in relation to FTT scales and 
risk-taking intentions. 
It is also important to take into account that the FTT scales used in the current study 
were specifically designed to test risk-taking intentions in an adolescent sample (see Mills et 
al., 2008). Thus, it is possible that this impacted on the results in the current study, which 
involved a sample of an older age group, compared to the adolescent sample involved in the 
original study from which the scales were adapted.   
 Moreover, the sample involved in the current study was a relatively older sample in 
terms of age, and most participants reported currently being employed (or students) and 
having completed some form of higher education, which is somewhat unrepresentative of the 
general BD population.  Further research may wish to recruit larger samples of younger and 
older participants to offer potential comparisons between age group, to clarify patterns of 
response in FTT measures. 
 Finally, due to the use of online questionnaires, it was difficult to control response 
rate and to ensure that participants who took part in the study completed all measures 
administered.  This led to missing data and incomplete responses.  Future studies may wish to 




consider face-to-face methods to overcome some of the abovementioned limitations faced by 
the current piece of research.  
5. Conclusions 
 This study found some promising results to help explain the links between FTT 
measures and risk-taking intentions in BD.  The main finding was that gist and verbatim 
representations are both independent predictors of risk-taking intentions in the sexual, ethical 
and health/safety domains, even after controlling for mood and impulsivity.  This offers a 
new conceptualisation of the mechanisms behind risk-taking in BD, which move away from 
the traditional idea that risk-taking is simply the result of impulsivity and mood fluctuations 
in this clinical population, towards a more complex framework based on the idea of a 
“reasoned route” to risk-taking. 
 The findings had some clinical implications, particularly regarding the development 
of new preventative interventions to target risk-taking as well as treatment non-adherence, 
which are common problems in people diagnosed with BD.  Further research would be of 
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Table 1.  Demographic and clinical information 
Variable  
Age, Mean(SD), [Range] 49 (15), [21-78] 
Female, n (%) 39 (68) 
In employment/Students, n (%) 34 (59) 
Native English Speakers, n (%) 50 (86) 
Attended Higher Education, n (%) 49 (85) 
  
Ethnicity, n (%)  
     White British/White Other 49 (85) 
      Asian 3 (5) 
      Mixed 1 (2) 
      Black/African/Caribbean 1 (2) 
      Other Ethnic Background 4 (7) 
  
Time since diagnosis, n (%)  
      In the past year 3 (5) 
      In the past 2-5 years 13 (23) 
      In the past 6-10 years 15 (26) 
      In the past 11-15 years 10 (17) 
      More than 16 years ago 17 (29) 
       
Diagnosis Type, n (%)        
      Bipolar Type I 19 (33) 
      Bipolar Type II 27 (46) 
      Bipolar NOS 11 (19) 
      Schizoaffective Disorder 1 (2) 
  
Number of BD episodes experienced, n (%) 
      Between 0-5 episodes 
      Between 6-10 episodes 
      Between 11-20 episodes 







Currently in psychological therapy, yes, n (%) 11 (19) 
      Cognitive Behavioural Therapy 2 (3) 
      Counselling 2 (3) 
      Psychotherapy 3 (5) 
      Other/Not specified 
 
4 (7) 
Currently receiving BD medication yes, n (%) 
      Combination 
      Mood Stabilizers 
      Antipsychotics 
      Antidepressants 







Currently experiencing a mood episode yes, n (%) 35 
Last mood episode more than 6 months ago, n (%) 24 
Other comorbid diagnoses yes, n (%) 23 
 
 




Table 2.  Reliability Analysis 
Scale Cronbach’s alpha 







Barratt Impulsiveness Scale (BIS) .90 
  BIS Non Planning Subscale .83 
  BIS Motor Subscale .87 
  BIS Attentional Subscale 
 
.75 
DOSPERT Risk-Taking  
  Ethical Subscale .65 
  Financial Subscale .77 
  Health/Safety Subscale .72 
  Recreational Subscale .86 
  Social Subscale 




DOSPERT Risk-Perception        
  Ethical Subscale .68 
  Financial Subscale .82 
  Health/Safety Subscale .70 
  Recreational Subscale .88 




Fuzzy Trace Theory Scales  
  Categorical Risk Scale .79 
  Gist Principles Scale .80 













Table 3.  Distribution of scores and normality scores for individual scales 
Scales Mean (Range) SD Shapiro-Wilk 
Categorical Risk 24.77 (4-36) 5.89 .92 
Gist Principles 20.93 (15-28) 3.20 .97 
Global Risk .29 (0-2) .56 .56*** 
Specific Risk 7.10 (5-25) 4.08 .56*** 
Quantitative Risk .97 (0-10) 2.17 .52*** 
DOSPERT RT    
      Ethical 16.85 (6-34) 7.15 .95* 
      Financial 13.37 (6-30) 7.15 .88*** 
      Health/Safety 21.15 (6-42) 8.79 .97 
      Recreational 19.78 (6-42) 10.80 .93** 
      Social 32.25 (12-42) 7.43 .92** 
      Sex 6.93 (2-14) 3.87 .90*** 
7up 12.17 (7-27) 5.33 .87*** 
7down 14.94 (7-28) 6.58 .91*** 
BIS 28.48 (8-50) 9.12 .99 











Figure 1.  Mean Scores and standard error for individual FTT scales 
 


















































Figure 3.  Scores Distribution for Quantitative Risk Scale 
 















































Figure 5.  Scores Distribution for Categorical Risk Scale 
 








































































Table 4.  Correlations between clinical variables and risk-taking intentions 
Clinical Variable DOSPERT Subscale 
 Ethical Financial Health/Safety Recreational Social Sex 
BD-I vs other BD .17 .02 .13 .04 .20 .28* 
Early onset vs late¥ -.16 -.19 -.12 -.19 .10 -.14 
Mood episode (yes) .19 .35* .25 .25 .08 .08 
Number of episodes¥¥ .17 .24 .27* .32* .15 .18 
Note: *p<.05 **p<.01 ***p<.001 
¥ Partial correlation, controlling for age (n=55).  
¥¥ Partial correlation, controlling for age (n=55).  
 
Table 5.  Correlations between FTT scales 
Scale CategRisk GistPrinc GlobalRisk¥ SpecRisk¥ QuantRisk¥ 
Categorical Risk - -.18 -.01 -.27* -.21 
Gist Principles -.18 - .29* .21 .35** 
Global Risk¥ -.01 .29* - .26 .29* 
Specific Risk¥ -.27* .21 .26 - .53** 
Quantitative Risk¥ -.21 .35** .29* .53** - 


















Table 6.  Correlations between FTT scales and risk-taking intentions 
Scales DOSPERT Risk-Taking 
 Ethical Financ Health/S Recreat Social Sex 
SpecRisk1¥ .26* .29* .46** .09 .19 .44** 
Quant¥ .44** .49** .40** .21 .15 .48** 
CategRisk -.03 -.10 -.09 .07 .21 .03 
GistPrinc .40** .19 .36** .23 .21 .49*** 
GlobalRisk¥ .26 .31* .27 .01 .22 .42** 
Note: BIS = Barratt Impulsiveness Scale; SpecRisk = Specific Risk Scale; Quant = Quantitative Risk 
Scale; CategRisk = Categorical Risk Scale; GistPrinc = Gist Principles Scale; GlobalRisk = Global 
Risk Question.  1Scores for the Specific Risk Scale are based on the sample with the two outliers 
removed (n=56).  *p<.05; **p<.01 ***p<.0001.  
¥Spearman’s rho 
 
Table 7.  Hierarchical Regression model for FTT scales and mood predicting DOSPERT Sex 
Subscale 
Variables R2 ΔR B (SE) 95% Confidence Interval 
    Lower Upper 
Step1 – Intercept .29 .29*** .77 (1.44) -2.11 3.65 
7up – (hypo)mania   .29 (.08) .12 .45 
7down - Depression   .17 (.07) .03 .31 
Step 2 – Intercept .44 .16** -7.39 (2.63) -12.68 -2.10 
7up – (hypo)mania   .20 (.08) .04 .35 
7down - Depression   .09 (.07) -.04 .22 
Gist Principles   .38 (.13) .12 .64 
Specific Risk   .39 (.19) .02 .76 





Table 8.  Hierarchical Regression model for FTT scales and impulsivity predicting DOSPERT Sex 
Subscale 
Variables R2 ΔR B (SE) 95% Confidence Interval 
    Lower Upper 
Step1 – Intercept .10 .10* 3.15 (1.61) -.08 6.39 
BIS Total Score   .13 (.05) .03 .24 
Step 2 – Intercept .37 .27*** -7.99 (2.85) -13.72 -2.27 
BIS Total Score   .07 (.05) -.02 .17 
Gist Principles   .47 (.13) .21 .73 
Specific Risk   .47 (.19) .08 .85 
Note: Overall Model - F(3, 52)=10.54, p<.001; *p<.05, **p<.01, ***p<.001 
 
Table 9.  Hierarchical Regression model for FTT scales and mood predicting DOSPERT Ethical 
Subscale 
Variables R2 ΔR B (SE) 95% Confidence Interval 
    Lower Upper 
Step1 – Intercept .22 .22** 6.94 (2.82) 1.28 12.60 
7up – (hypo)mania   .52 (.16) .20 .85 
7down - Depression   .21 (.14) -.06 .48 
Step 2 – Intercept .33 .11* -5.73 (5.42) -16.61 5.15 
7up – (hypo)mania   .38 (.16) .06 .70 
7down - Depression   .08 (.13) -.19 .35 
Gist Principles   .58 (.27) .04 1.12 
Specific Risk   .67 (.38) -.10 1.43 





Table 10.  Hierarchical Regression model for FTT scales and impulsivity predicting DOSPERT 
Ethical Subscale 
Variables R2 ΔR B (SE) 95% Confidence Interval 
    Lower Upper 
Step1 – Intercept .29 .29*** 4.69 (2.69) -.71 10.08 
BIS Total Score   .42 (.09) .24 .60 
Step 2 – Intercept .42 .13** -10.20 (5.14) -20.52 .12 
BIS Total Score   .34 (.09) .17 .52 
Gist Principles   .65 (.24) .17 1.12 
Specific Risk   .56 (.35) -.14 1.25 
Note: Overall Model - F(3, 52)=12.79, p<.001; *p<.05, **p<.01, ***p<.001 
 
Table 11.  Hierarchical Regression model for FTT scales and mood predicting DOSPERT 
Health/Safety Subscale 
Variables R2 ΔR B (SE) 95% Confidence Interval 
    Lower Upper 
Step1 – Intercept .23 .23** 8.55 (3.34) 1.85 15.25 
7up – (hypo)mania   .42 (.19) .04 .80 
7down - Depression   .48 (.16) .16 .80 
Step 2 – Intercept .33 .10* -3.98 (6.47) -16.97 9.02 
7up – (hypo)mania   .26 (.19) -.12 .64 
7down - Depression   .34 (.16) .02 .67 
Gist Principles   .50 (.32) -.14 1.15 
Specific Risk   .95 (.46) .03 1.86 





Table 12.  Hierarchical Regression model for FTT scales and impulsivity predicting DOSPERT 
Health/Safety Subscale 
Variables R2 ΔR B (SE) 95% Confidence Interval 
    Lower Upper 
Step1 – Intercept .29 .29*** 6.68 (3.22) .23 13.14 
BIS Total Score   .51 (.11) .29 .72 
Step 2 – Intercept .42 .13** -9.54 (6.19) -21.96 2.89 
BIS Total Score   .41 (.10) .20 .62 
Gist Principles   .65 (.28) .09 1.22 
Specific Risk   .83 (.42) -.01 1.67 
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Integrating diagnosis-led quantitative research in clinical psychology practice 
 
Introduction 
 The findings of the systematic review and the research paper provided promising 
results to help conceptualise risk-taking behaviour in people diagnosed with Bipolar Disorder 
(BD).  The review provided strong evidence supporting the idea that BD is indeed 
characterised by higher rates of risk-taking behaviours, particularly during manic states, 
offering a helpful summary of the contrasting pieces of research available in the field.  
Another important finding of the systematic review was the identification of certain clinical 
and demographic predictors of risk-taking in this population, which remains an 
underexplored aspect of research in BD, despite its high clinical relevance.  These findings 
were discussed in relation to several limitations of the current literature, identified in the 
review, as well as in the design of the studies involved, including an over-reliance on self-
report and laboratory measures, which make it challenging to generalise the results. 
 Within the context of risk-taking behaviours in BD, the research paper offered a 
helpful addition to the findings of the systematic review, in that it provided an interesting new 
conceptualisation of risk-taking behaviours in BD, which goes beyond traditional studies in 
the field attributing such behaviours to impulsivity and mood states (particularly mania).  In 
fact, the results showed that constructs proposed by Fuzzy Trace Theory (FTT; Reyna and 
Rivers, 2008; Rivers et al., 2008) significantly predicted risk-taking intentions even after 
controlling for the effects of impulsivity and mood.  These results are promising in that they 
move away from the idea of risk-taking as an impulsive act, which cannot be controlled and 
toward FTT ideas of a “reasoned route” to risk-taking.  This new conceptualisation is 
clinically relevant in light of studies conducted by Reyna and colleagues (e.g., Reyna et al., 
2015; Reyna and Mills, 2014), which involved FTT principles to successfully design risk 





limitations were observed in the methodology of the research paper.  In particular, a relatively 
small sample size made it challenging to answer some of the questions arising from the 
results because, in order to preserve statistical power, it was necessary to limit the number of 
variables entered in the regression models utilised.  
 A discussion of the results and limitations of the two pieces of research was presented 
in detail in each individual paper.  Thus, the current critical review aims at offering a 
reflective discussion on the process of conducting quantitative research as a trainee clinical 
psychologist.  There will be a particular focus on the personal dilemma resulting from 
adopting diagnostic criteria in research, whilst continuing to utilise formulation-based 
thinking as a default position.   
To achieve this aim, this critical review will first consider some of the strengths and 
limitations of both diagnosis and formulation within the context of research and clinical 
practice.  Subsequently, the difficulties of conducting research involving people diagnosed 
with BD will be discussed.  Finally, these reflections will be integrated within a discussion of 
the changing role of clinical psychologists, offering ideas on how clinical psychologists can 
attempt to resolve this conflict between two contrasting paradigms in their roles as “scientist 
practitioners”.   
Diagnosis versus formulation: a constant tension 
 Working within the field of clinical psychology, it soon becomes apparent that there is 
a real tension between the diagnostic paradigm, adopted by most our medical colleagues, and 
the formulation-based paradigm, which clinical psychology promotes (The British 
Psychological Society, 2011).  Currently, diagnosis appears to be the predominant paradigm 
in mental health services, despite a recent rise in interest in psychological formulation.  In 
recent years, with the publication of the Diagnostic and Statistical Manual of Mental 





been under scrutiny by both clinicians and researchers alike, which makes this review 
particularly timely.   
Diagnoses are usually conceptualised as “labels” that help us categorise “clinical 
populations” according to common symptoms and patterns (Macneil et al., 2012).  This 
categorisation has been found to be helpful both in research and clinical practice, as it helps 
predict outcomes, inform pharmacological treatment and allows for a clustering of clinical 
populations, which is helpful when conducting research and designing specialised mental 
health services. 
However, despite its helpful aspects, diagnosis has been widely criticised for being 
intrinsically flawed, as it appears to be based on a surface-level categorisation of symptoms 
and disregard entire aspects of people’s experiences.  In fact, one of the main problems with 
this practice is that a “label” tells us little (if any) information about causation; knowing that 
someone has a diagnosis of “schizophrenia”, does not provide any information about what 
factors might have triggered, contributed to, and maintained that person’s difficulties 
(Kendell and Jablensky, 2003).  
Moreover, diagnosis also provide no information about the client’s experience of that 
particular “condition”; it is often limited to a description of symptoms that does not take into 
account the person’s relationship with their difficulties and how they react to their symptoms 
(Macneil et al., 2012).  It also often lacks cultural validity, as it fails to take into account the 
person’s cultural context and how this may have contributed to the development of a set of 
experiences that are classed as “symptoms”, making it a problem-focused approach (Canino 
and Alegría, 2008; Hinton and Lewis-Fernández, 2011).   
Another common critique of diagnosis is that it lacks validity.  Diagnoses are not 
discrete entities with concrete boundaries, but tend to often overlap with one another.  In fact, 





The boundaries of diagnosis seem to have been steadily expanding over the years, as 
psychiatrists struggle to distinguish people who “fit” the criteria for a certain “illness” from 
those who do not (Frances, 2013).  This has caused some critics to claim that diagnosis might 
be pathologising what could be conceptualised as normal human experiences in the context of 
the person’s individual life course (e.g., Allen, 2013; Maj, 2014). 
In recent years, there has been a reconsideration of diagnostic concepts such as 
“schizophrenia” (Wong, 2014), “personality disorders” (Kim and Tyrer, 2010) and “bipolar 
disorder” (Ghouse et al., 2013; Vieta and Phillips, 2007).  These diagnoses have been put 
under scrutiny by both psychiatrists and clinical psychologists calling for a re-evaluation of 
the language used within mental health services (May, 2007; Moncrieff, 2007).  
Kinderman and colleagues (2013) urged clinicians to “drop the language of disorder”, 
in an attempt to redefine some of these concepts (diagnoses) within clinical practice.  In the 
context of this critique, clinical psychologists have played an important role in advocating for 
an alternative approach, which sees formulation at the centre of client care (The British 
Psychological Society, 2011).  Nonetheless, a detailed critique of diagnostic criteria is 
beyond the scope of this critical review.  
From the evidence abovementioned, it is evident that the shortfalls of diagnostic 
systems are well documented in clinical psychology research; formulation is often offered as 
the “better alternative” to the limitations of the available diagnostic systems.  However, this 
alternative paradigm is not free of limitations.  Psychological formulation has been a core 
skill for clinical psychologists (Health & Care Professions Council, 2015; The British 
Psychological Society, 2011) since the emergence of the “scientist-practitioner” model in the 
1950s.  It is commonly understood as a process whereby the therapist and the client develop a 
“shared understanding” of the client’s presenting difficulties and develop “working 





2011).  As such, this “working hypothesis” is something that needs to be tested and it can 
shift and change as therapy progresses and new information comes to light (Harper and Moss, 
2003).  Psychologists use formulation as a link between psychological theory, evidence base 
and practice.  One of the main differences between a psychological formulation and a 
medical diagnosis is that formulation is not based on “truth” or “certainty”, it is not meant to 
be a label to define someone’s “problems” and “symptoms”, but rather a useful account, 
developed collaboratively with the client, of the client’s history and presenting difficulties 
(Johnstone, 2006).   
Formulation is considered particularly helpful in clinical practice as it is developed 
collaboratively with clients and often based on the core idea that “…at some level it all makes 
sense” (Butler, 1998, p. 2) and that, although someone’s difficulties may appear confusing, 
chaotic, challenging and upsetting, when considered within the person’s context, their 
experiences make sense.   
One of the aspects which, in my opinion, is most rewarding about developing a 
formulation with our clients is when there is an almost surprising realisation that their 
experiences are not as “unusual” and “abnormal” as they once thought, but that they serve a 
function.  This can have an incredibly validating effect for our clients, who have often 
experienced stigma (both from society as well as internalised stigma), and it can be the key to 
success in psychological therapy. 
However, despite its strengths, a fundamental problem with formulation stands in its 
definition; although the term “formulation” is widely used in clinical practice, people seem to 
attribute different meanings to it (Flinn et al., 2015).  It is interesting to consider the idea of 
inter-rater reliability regarding formulations; one of the main critiques brought forward in 
relation to diagnosis, is that it often shows poor inter-rater reliability, thus arising doubts 





the claim, as clinical psychologists, that there can be different formulations of a client’s 
difficulties and that they are based on “usefulness” rather than “truth”, we may be risking 
invalidating what could be a very helpful tool to be used, not only in clinical psychology, but 
across different disciplines. 
Moreover, in my opinion, as formulation is predominantly based on a clinician’s skills 
and knowledge, it has as much potential for being “pathologising” and “invalidating” as its 
diagnosis counterpart if approached in unhelpful ways.  Finally, it is important to consider 
that, as formulation is becoming increasingly accepted in clinical practice and some research 
approaches, it is open to criticism regarding its reliability and validity.  It was aforementioned 
how inter-rater reliability has been considered to be problematic and its validity still seem to 
be overwhelmingly unexplored.   
Diagnosis and formulation are both approaches that have strengths and limitations, 
which can create a state of tension between these two paradigms, which is particularly 
relevant when, as clinical psychologists, we embark in the task of conducting research 
involving clinical populations. 
 The British Psychological Society (BPS, 2014) outlined the role of clinical 
psychologists stating the following: 
  “Clinical psychologists are trained to reduce psychological distress and to enhance 
and promote psychological wellbeing by the systematic application of knowledge derived 
from psychological theory and research” (p. 5). 
It is evident from the statement above that research is a key aspect to consider when 
discussing the role of clinical psychologists.  We are considered “reflective scientist 
practitioners” and expected to base our practice on the available evidence-base in our work 
with clients, as well as contribute to the development of the evidence-base.  It is in this 





Although formulation offers a more in depth account of a client’s story and thus is of 
incredible value in clinical practice, research remains largely dominated by diagnostic 
paradigms (Boyle, 2007).  This is particularly true for quantitative research where, in order to 
design studies with a certain rigour and validity, strict categorisations based on diagnostic 
criteria are still used as a “gold standard” (Zwarenstein et al., 2008).  As a trainee clinical 
psychologist conducting quantitative research, this causes a significant dilemma; in fact, as 
we advocate and criticise diagnosis in our clinical practice, we are “forced” to embrace these 
concepts in our researcher roles. 
Characterising Bipolar Disorder in research 
In attempting the task of conducting my thesis on risk-taking behaviour in Bipolar 
Disorder (BD), I was faced with the dilemma of having to decide on criteria to characterise a 
group of people to take part in my study.  As a trainee clinical psychologist, this caused 
several challenges.  The first difficulty arose as I realised that, in order to proceed with the 
study, it was necessary to reflect on my personal position on the general idea of diagnosis.   
Although I agree with the position of clinical psychologists in criticising diagnosis, I 
am not completely opposed to the concept.  I believe that diagnostic criteria can serve a 
helpful function in helping us characterise “common experiences” and communicate with 
other professions using commonly understood terms.  Diagnoses can be conceptualised as 
“labels”, which can be particularly helpful when conducting research.  Nonetheless, with 
diagnosis comes a degree of “power” that I find incredibly dangerous.  In the UK, psychiatric 
diagnosis can be utilised to mandate “involuntary treatment”, which can generate stigma and 
a sense of powerlessness for our clients as they undergo their therapeutic journeys through 
mental health services (Hayne, 2003; Rüsch et al., 2013).  Thus, the problem with diagnosis, 
in my opinion, stands in the way it is used and the significant power it still holds rather than 





The power diagnosis holds is of high relevance to BD, particularly when considering 
its limitations.  The diagnosis of BD has been topic of heated debates since its conception 
with the idea of “manic-depressive insanity” brought forward by Kraepelin in the 1890s 
(Jablensky, 1999).   In its latest diagnosis-based form, BD is conceptualised as a cyclical 
condition, characterised by episodes of both (hypo)mania and depression, as well as an array 
of other symptoms (American Psychiatric Association, 2013). 
The cyclical nature of BD poses significant problems when considering the validity of 
its diagnosis.  Three main challenges in diagnosis BD have been identified.  First, diagnostic 
criteria for BD are based on the idea of a “typical pattern” of (hypo)manic and depressive 
episodes, which is often not applicable in real-life where the experiences of people with a 
diagnosis of BD vary considerably (Vieta and Phillips, 2007).  Second, BD encompasses a 
range of symptoms that are too generic and can often overlap with those of other diagnoses 
(Vieta and Phillips, 2007).  Third, a high comorbidity between diagnoses of BD and 
substance abuse has been observed in research (e.g., Sherwood Brown et al., 2001); certain 
substances, such as cocaine, have been found to mimic the mood fluctuations typical of 
(hypo)manic episodes of BD (Morton, 1999), thus posing a significant challenge when 
attempting to distinguish between the two. 
To address some of the abovementioned challenges, researchers formulated the idea 
of a “bipolar spectrum”, which has also been considered in the latest version of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (American Psychiatric 
Association, 2013), applicable to those clients who do not meet strict criteria for diagnosis 
(Ghaemi, 2013).  However, this concept has been often criticised as it is seen to blur the 
boundaries between normal human experiences and psychiatric diagnoses (Zorumski and 






 Attempting to answer this question is not an easy task.  It is difficult to ignore the 
numerous pieces of research outlining the limitations of BD diagnosis, which seem to suggest 
that it is not a valid concept.  Nonetheless, at present there seem to be a lack of valid 
alternatives to diagnosis that can be applied in psychology research.  The integration of 
diagnosis in research will be further discussed in the next section. 
Integrating diagnosis and formulation in research 
 It was briefly mentioned earlier in this paper how both diagnosis and formulation 
have strengths and limitations that need to be considered when evaluating these two concepts.  
Regarding research, diagnosis can be helpful in that it can offer commonly understood 
“labels” that can be adopted to categorise clinical populations with “common features” to 
investigate certain phenomena that otherwise would be challenging to explore.  Nonetheless, 
diagnosis remains limited in terms of accounting for individual differences and the nuances 
observed in different “conditions”.  Conversely, the idiosyncratic nature of formulation-based 
approaches could be helpful in research to explore the links between results and clinical 
applications, to translate research findings into real-life situations.  However, formulation still 
has significant limitations in terms of categorisation, as it faces the problem of perhaps being 
“too idiosyncratic”.   
Consequently, I believe that by celebrating one whilst demonising the other poses a 
significant challenge for psychologists and other clinicians alike.  In fact, one question must 
be considered in this debate: How can we maintain scientific rigour in research if we 
completely demolish diagnosis?   
Recent years have seen an increase in qualitative research methods in psychology, 
which are less reliant on diagnosis and strict categorisations, and more focused on individual 
experiences (Dixon-Woods et al., 2006; Meyrick, 2006).  Nonetheless, qualitative approaches 





quantitative counterpart.  In fact, quantitative research is still considered somewhat 
“superior” to qualitative approaches by many researchers, and Randomised Controlled Trials 
(RCTs) remain the “gold standard” of psychological research methods (Zwarenstein et al., 
2008).  It is interesting to note how opposing the clinical and research fields still are within 
clinical psychology.  On one side, we have countless reflective articles and position papers 
advocating for formulation-based approaches in clinical practice.  Yet, clinical psychology 
research is still dominated by diagnosis-based approaches.   
This fragmentation is not limited to individual research studies but it is also reflected 
in clinical psychology guidance, which provides most the evidence-base for clinical practice.  
In fact, despite their recognition of the flaws in diagnostic criteria, published guidance by the 
National Institute for Health and Care Excellence (NICE) is still deeply rooted in diagnostic 
systems.  Researching NICE publications, it soon becomes evident that there is guidance for 
“bipolar disorder”, “depression”, “Post-Traumatic Stress Disorder” and many other, which 
appear to be diagnosis-led.   
 One of the main reasons for this phenomenon is perhaps the fact that, despite the 
utility of formulation in both direct and indirect work with clients, we are still far from 
reaching a common agreement on how formulations are developed, which leaves this helpful 
practice open to criticism.  I believe that, as clinical psychologists, we have a duty to push for 
the development of alternatives to diagnosis as this practice causes significant challenges for 
both clients and clinicians.   
Mental health diagnosis is still surrounded by incredible stigma in society (Ben-Zeev 
et al., 2010; Corrigan, 2007) and, although receiving a diagnosis might be helpful for some 
clients, the negative consequences of this practice often outweigh the positives (Hayne, 
2003).  Mental health stigma has been found to be associated with low self-esteem (Link et 





significant difficulties in the long term as clients experience a lack of social support and 
struggle to access services in a timely manner (Corrigan et al., 2014).   Moreover, diagnosis is 
still predominantly based on a “disease model” (Deacon, 2013; Volkow et al., 2015), which 
can cause further psychological harm as clients are surrounded by unhelpful narratives about 
their difficulties and hinder recovery (Yanos et al., 2010). 
 However, for the purpose of research, it is important to acknowledge that, as a 
profession, we are still far from developing a helpful paradigm that can substitute the utility 
of diagnostic criteria in categorising clinical populations whilst attempting to preserve 
scientific rigour.  Therefore, I believe that it is unhelpful to create a state of constant tension 
between professions embracing formulation as their default position and those relying on 
diagnostic frameworks.  In fact, this practice can be detrimental, not only as it can prevent 
collaboration, but also as it can generate confusing messages for our clients, which can 
impact on their therapeutic journey through mental health services. 
Bridging the gap between diagnosis and formulation in research is a challenging task 
and it can be conceptualised as part of a wider divide between clinical research (and the 
development of the evidence base) and clinical practice.  A possible way forward is to 
explore this crucial issue during clinical training, which can be conceptualised as a “golden 
period” in a clinical psychologist’s career where, as trainees, we are in close contact with 
both the worlds of research and clinical practice.  This is a unique opportunity that could be 
utilised to develop creative approaches to start integrating psychological formulation in 
clinical research and develop research models that incorporate both formulation and 
diagnosis.   
 This challenging, but in my opinion achievable task, could be achieved by perhaps 
considering the way in which, as clinical psychologists, we use diagnosis in our research and 





believe that it is of vital importance to keep a critical eye when utilising diagnostic labels in 
research and focus on relating research findings to clinical implications, whilst keeping in 
mind the idiosyncratic experiences of clients who may share a similar diagnostic label.   
How does this apply to clinical practice? 
 Mental health services in the UK are still predominantly structured around psychiatric 
diagnosis; from the point of referral to access to treatment and therapy, the diagnostic 
framework prevails.  Clinical psychologists working within this diagnosis-dominated system 
need to be familiar and utilise diagnostic concepts, particularly in light of their changing role.  
Clinical Psychologists are increasingly expected to integrate indirect ways of working within 
their practice, in addition to direct client work, as it was outlined by the Department of Health 
(2007) in their document “Mental Health: New Ways of Working for Everyone”.  As part of 
this role shift, psychologists are asked to provide consultation and supervision to other 
professional groups, whose practice is based within the diagnostic paradigm.  Thus, clinical 
psychologists must be able to work with diagnosis, whilst integrating their formulation-based 
knowledge in their practice, in order to ensure best quality of care for the clients and enhance 
staff teams’ understanding of the client’s difficulties. 
 Moreover, mental health services within the NHS are currently commissioned based 
on the “payment by results” system, which is predominantly based on diagnosis and outcome 
measures to operationalise “complexity” and “successful treatments” (Department of Health, 
2011).  An important part of the role of clinical psychologists working within the NHS is to 
develop service provision to improve clients’ access and journeys through services.  Thus, 
due to the current prevalence of diagnostic concepts in decisions involving funding and 
development of services, it is of crucial importance for clinical psychologists to be familiar 





Clinical psychologists are increasingly occupying senior positions with the National 
Health System (NHS).  In relation to the integration of diagnosis and formulation in clinical 
practice, it is important to think creatively about the ways in which we work within a wider 
clinical team and consider our role within the NHS to promote positive change.  As 
individuals, for instance we could start by continuing to introduce formulation-based ways of 
working within a wider team context and promoting a critical approach to the use of 
diagnosis.  Nonetheless, it is important to acknowledge that shifting a paradigm that has been 
dominant for several decades will take time and effort from individuals but most importantly 
from the profession as a whole and the professional bodies involved (e.g. British 
Psychological Society; Health and Care Professions Council). 
Conclusions 
 This review discussed the strengths and limitations of both diagnosis and formulation.  
Specific challenges in relation to the diagnosis of BD were also considered in relation to 
conducting quantitative research with people diagnosed with BD.  It was outlined how 
diagnosis can serve as a helpful tool both in research and clinical practice as it can offer a 
clustering system that is shared across different disciplines and aid communication between 
practitioners working within mental health services.  Therefore, it was advocated that clinical 
psychologists must be familiar with diagnostic systems and able to utilise these within their 
roles both as clinicians and researchers.  This is of relevance due to the current limitations of 
formulation in light of its idiosyncratic nature and the difficulties caused by this in relation 
characterising common experiences in research.   
 At present, formulations, although helpful at an individual client level, are unable to 
replace the current diagnostic system.  Future research should focus on further examining the 
validity of formulation and its inter-rater reliability, as well as consider the role of 
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Due	 to	 the	 nature	 of	 the	 study	 (online	 questionnaires)	 no	 discomfort	 to	 participants	 is	
anticipated.	However,	 participants	will	be	 informed	to	contact	their	GP	and/or	care	team	



























































































































Decision making and risk taking is one of the most studied topics in developmental 
neuroscience. It is a particularly relevant topic to people diagnosed with bipolar disorder 
(BD) who often show altered decision making processes that lead to a higher likelihood to 
engage in risky behaviours. This is not limited to the manic and depressive stages of BD, but 
also present during its euthymic stage (Chandler, Wakeley, Goodwin, & Rogers, 2009). 
Numerous theories have been developed to try to explain why people with BD are more 
likely to engage in risk taking behaviours compared to the general population; nonetheless 
researchers are yet to reach a consensus on this topic. 
Decision Making in Bipolar Disorder 
Numerous studies have attributed risky behaviour in BD to impulsivity, a trait that has been 
found to be characteristic of the disorder. For example a study by Strakowski and colleagues 
(2010) found that people with BD were more impulsive in their responses to three 
behavioural tasks, compared to healthy controls. This finding was mainly observed in the 
manic stage of the illness, with the results normalising during the depressive or euthymic 
stages. However, people with BD showed elevated scores in the Barrett Impulsivity Scale 
(BIS-11) across all stages of the illness. Mason and colleagues (2012) also observed a 
preference for immediate over delayed (but often superior) rewards in people at risk for 
developing bipolar, which is also linked to impulsive behaviour. In fact a preference for 
immediate over delayed rewards often results in people making a decision that will lead to 
instant gratification over delayed gratification even if this decision is potentially more risky. 
A more recent study by Mason and colleagues (2014), also found an increased preference for 
lower-order (short-term) goals, as opposed to higher-order (long-term) goals in people with 
BD compared to healthy controls, indicated by a hyperactivation of the ventral striatum (an 
area of the brain associated with shorter-term goals, as opposed to the dorsolateral prefrontal 
cortex associated with longer-term goals). Conversely a study conducted by Martino, 
Strejilevich, Torralva, and Manes (2011) found that people in an euthymic stage of BD did 
not show impairment in decision making abilities, and were able to make complex decision 
in efficient ways. Thus the authors report that the impairment in decision making observed 
in BD, might in fact be characteristic of the acute stages of BD rather than of BD as a whole. 
Moreover, evidence suggests that, although people diagnosed with bipolar disorder often 
show abnormalities on self-report measures of impulsivity (consistently with the literature 
cited above), they do not consistently show impairment in behavioural tasks requiring 
planning and forethought (Holmes et al., 2009; Lombardo et al., 2012). Therefore it is 
possible that the processes underlying risk-taking in people diagnosed with BD might be 
more complex than it is hypothesised in the impulsivity literature. 
Research around decision making in BD to date is fragmented, and does not offer a coherent 





people diagnosed with BD. Clarifying risky decision making in BD is paramount for clinical 
practice and to improve clinical outcomes in this population. In fact research in BD also 
reports poor adherence to both psychological (e.g., Busby and Sajatovic, 2010) and 
pharmacological interventions (e.g., Gonzalez-Pinto et al., 2010) in the majority of people 
diagnosed with BD. Despite the availability of studies attempting to clarify the reasons why 
people diagnosed with BD often show poor adherence to intervention (e.g., Arvilommi et al., 
2014), only a limited number of studies has attempted to offer suggestions to improve 
adherence/attendance in clinical practice. 
Fuzzy trace theory 
Historically, developmental theories of decision making have predicted an improvement in 
reasoning ability from childhood to adulthood (e.g., Bjorklund, 2012), implying that 
reasoning becomes more analytical (verbatim) and less intuitive (gist-based) in adulthood 
(Byrnes, 2002; Stanovich, Toplak, 
& West, 2008). Nonetheless, the idea that adults reason better than children has been 
challenged by studies showing developmental reversals indicating that adults are more 
susceptible to bias and that children surprisingly have better reasoning abilities than adults 
(De Neys & Vanderputte, 2011; Reyna & Farley, 2006). 
For instance, if it is true that more advanced thinking is based on the thorough considerations 
of risks and rewards, advanced thinkers (e.g. adults), would choose a risky option if this 
presented favourable odds.  However evidence suggests that adults are often risk-averse 
even when presented favourable odds (Reyna & Brainerd, 2011) thus suggesting that the 
development of decision-making from childhood to adulthood (or from less to more 
advanced) is not as straightforward as originally hypothesised. 
A recent theory developed by Reyna (2008), called fuzzy-trace theory (FTT), tried to clarify 
the processes behind decision making and risk-taking behaviours in non-clinical populations, 
and offered interesting links to clinical practice that could be highly relevant to clinical 
psychology. FTT suggests that people record their experiences by creating verbatim and gist 
representations of their experiences. 
Verbatim representations are mental representations of daily experiences that are recorded as 
similar as possible to the ‘original’ experience, thus capturing the information in the exact 
form it was originally presented (i.e. it is a literal, or a verbatim representation). A gist 
representation is a more vague representation that captures what the person perceives as the 
‘bottom line’ meaning of the information recorded; it is subjective, and it is influenced by 
different factors (e.g., emotional state, educational and cultural background, developmental 
stage). 
Reyna’s theory is in contrast with the traditional understanding of the development of 
decision- making processes across the life span. According to Reyna (2008, 2015), more 
efficient (or advanced) decision making processes are characterised by gist-based thinking 





a more intuitive process rather than on the thorough trade-off between risks and rewards. For 
example in a situation involving sexual risk, in verbatim-based thinking the following 
decision-making process is triggered:  
1) the benefits of sex are large 
2) the objective risks of contracting HIV while engaging in unprotected sex are very 
small 
3) Decision: it is ok to have unsafe sex, as I will most likely not contract HIV. 
 
Conversely in gist-based thinking, the decision-making process is different as follows: 
1)  It only takes once to contract HIV 
2) Decision: I must use condoms/unsafe sex is not a good option. 
As shown in the two examples above, people who are more likely to take risks, tend to rely 
on verbatim representations rather than gist representations, thus implying the idea of a 
“reasoned route” to risk taking. The research around FTT (e.g., Reyna et al., 2011) also 
found that gist representations are typical of more mature and experienced decision makers; 
for example when comparing adolescents and adults, they found that adolescents (who are 
also more likely to take risks) relied largely on verbatim representations in their decision 
making processes, while adults were more reliant on gist representations. These findings 
were confirmed by neuroimaging data, which showed that when faced with the question ‘is it 
a good idea to swim with sharks?’, adolescents showed a higher activation of areas of the 
brain associated with reasoning and deliberation (representative of verbatim thinking), while 
adults showed activation in areas associated with intuition and gut responses (gist-based 
thinking) (Reyna & Farley, 2006). 
FTT also tried to offer some clarification on the observed relationship between emotion and 
decision making. For instance a paper by Rivers, Reyna and Mills (2008) suggests that 
positive and negative feelings states impact, in contrasting ways, on the way information is 
encoded (i.e., on the way mental representations are formed), and subsequently on decision-
making processes. The authors propose that positive feelings states (e.g. optimism) direct the 
decision maker’s attention to more global information, thus eliciting gist-based thinking and 
resulting in more efficient decisions. Conversely, negative feeling states (e.g. depression) 
direct the decision maker’s attention to detail, thus eliciting verbatim-based thinking and 
often resulting in risky decisions by prompting the more computational way of thinking 
discussed above, where there is a trade-off of risks and benefits. 
Similarly, the authors (Rivers, Reyna & Mills, 2008) also report evidence for the significant 
impact on arousal on decision-making. Arousal is believed to heighten the motivational 
effects of rewards, thus in a verbatim-based thinking process, where there is a trade-off of 
risks and benefits, decision-makers are even more likely to take risks as they tend to over-
estimate the benefits over the risks of their decision.  Interestingly, gist-based thinking was 





adolescents) are found to be more susceptible to arousal than more advanced thinkers (e.g. 
adults). 
The idea of a reasoned route to risk taking proposed in FTT offers an interesting framework 
to understand risk taking in bipolar disorder. In fact if high negative emotion, which 
characterises BD (Wessa, Kanske, & Linke, 2013), leads to a more analytical/verbatim 
thinking (as suggested by Rivers, Reyna and Millis, 2008), it is likely that risk taking in 
people diagnosed with BD is not simply due to impulsivity, but rather related to what appears 
to be a strong link between emotion and verbatim-based thinking. Clarifying where BD is 
placed on the continuum between verbatim and gist-based thinking could offer an innovative 
insight into the processes leading to risk taking in this population. This could potentially help 
to shift the idea that risk taking in BD is a result of impulsivity - which is often characterised 
almost as an intrinsic personality trait that cannot be overcome – to a less stigmatising idea 
that risk taking occurs on a normal continuum between verbatim and gist-based thinking. 
The current study 
The aim of the current study is to characterise a group of people in an euthymic stage of BD, 
using FTT gist and verbatim measures, and evaluate the associations of FTT styles (gist or 
verbatim – depending on results) in BD with self-report measures of risk perception, risk 
taking, impulsivity and response to punishment and reward, controlling for current mood. 
Research conducted to date on decision making in BD indicates the lack of a coherent 
framework for understanding decision making processes in people diagnosed with this 
condition. Moreover the majority of the studies cited above either lack, or are very limited in 
their clinical implications. 
FTT offers a good insight into decision-making processes as well as a link to possible 
interventions and clinical implications of the findings observed thus far. For example Reyna 
and colleagues (2015) were able to demonstrate that adolescents (who rely on verbatim 
representations) can be successfully trained to rely on gist representations, which results in 
an improvement in decision- making and a reduced likelihood to engage in risk-taking 
behaviours. This project would help to clarify the processes of decision making in people 
diagnosed with BD, as well as offer recommendations to improve adherence to medication 
and attendance in clinical practice. 
Clinical implications: the effectiveness of medication and psychological therapies for BD is 
still limited, especially in relation to risk-taking behaviours in this clinical group. Clarifying 
the process behind decision making and risk-taking in BP would be highly beneficial for 
clinical practice as it could lead to the development of new and more effective clinical 
alternatives. In fact interventions based on FTT models have been proved to be effective in 
improving decision-making processes by training people to use more ‘gisty’ or abstract 







Participants must be over 18 years of age to take part in the study and must have a diagnosis 
of Bipolar Disorder. Participants will be screened for bipolar disorder using the Mood 
Disorder Questionnaire, and their current mood state will be captured using the 7up and 
7down inventory. It is aimed to recruit between a minimum of 60 and a maximum of 100 
participants. There will be no gender restrictions. Participants must be English speakers to 
take part in the current project. 
Design 
This is a quantitative study, which will use anonymised online questionnaires on Qualtrics for 
data collection. Demographic and clinical information will be collected through individual 
items. Participants will be asked to report their age, gender, current employment (including 
voluntary employment), ethnic background, marital status and education level. Clinical 
information about current medication, past episodes of mania and depression and their 
duration, information about any comorbid diagnosis, age at diagnosis of bipolar, diagnosis 
type, number of episodes, current mood state, any other medical diagnosis (including HIV 
and STD) and any psychological therapy participants might have received, will also be 
collected. 
Procedure 
Ethical Approval. This project will not need ethical approval by the NHS Ethical Committee, 
as participants will be recruited online and through national charities. The project will be 
reviewed by the Faculty of Health and Medicine Research Ethics Committee (FHMREC) 
and submitted for approval to the University Research Ethics Committee (UREC). 
Recruitment. Recruitment will happen in two stages. First participants will be recruited online 
through Spectrum Connect (a database managed by the Spectrum Centre for Mental Health 
Research aimed at linking researchers with service users) and social media (Twitter; a 
research account will be set up and deleted with all its content once the study is complete). If 
not enough participants are recruited online, the second stage of the recruitment strategy will 
involve advertising the research through national charities (e.g., Bipolar UK, Mind UK), 
national support groups and advocacy groups and adverts in local and national periodicals 
(e.g. Pendulum – Bipolar UK). It is aimed to recruit between minimum of 60 and maximum 
of 100 participants. 
Consent. Potential participants will be directed to a link where they will be able to read an 
online information sheet before proceeding to the online questionnaires. Confidentiality and 
anonymity will be explained, and participants will be informed that no incentive will be 
provided. Consent will be obtained online: participants will be informed that by proceeding 
to the questionnaire they will be considered to have consented to take part in the study. No 
signed consent will be requested to protect participants’ anonymity. 





Participants will be directed to a link. Before being able to proceed to the questionnaires 
participants will be presented with an online information sheets outlining the study and 
explaining confidentiality and anonymity. If participants’ consent to take part they will then 
be asked some initial questions to collect demographic information (age, gender, 
employment status) and clinical information (current medication, past episodes of mania and 
depression and their duration, other comorbid diagnosis). Following this step, participants 
will be directed to the Mood Disorder Questionnaire (MDQ; Twiss, Jones, & Anderson, 
2008) followed by the 7up 7down scale (Youngstrom, Murray, Johnson, & Findling, 2013) to 
obtain information about their current mood state. They will then be able to complete the 
Gist and Verbatim scales (Millis, Reyna & Estrada, 2008) followed by the Barratt 
Impulsivity Scale (BIS; Patton, Stanford, 
& Barratt, 1995) and the Behavioural Inhibition Scale (BAS/BIS; Carver & White, 1994) 
measuring participants’ response to punishment and reward. Finally information about 
participants’ perception of risk and risk taking will be collected through the use of the 
Domain-Specific Risk-Taking Scale for adult populations (DOSPERT; Blais & Weber, 
2006). 
Practical Issues (e.g. costs/logistics) 
Costs. The only costs anticipated for the current study are the potential costs associated with 
adverts in periodicals. 
Ethical concerns 
Participants’ Confidentiality, anonymity and safeguarding concerns. Participants’ 
confidentiality and anonymity will be ensured by using anonymous online questionnaires. 
Participants will be asked to provide some demographic information (e.g. age, gender, ethic 
group), however names will not be required and no handwritten consent form will be 
required. 
Safeguarding concerns. Due to the nature of this study it is unlikely that safeguarding 
concerns will arise. However participants will be informed to contact their GP and/or care 
team (if involved with services) in case of distress. Further resources will be provided on the 
information sheet (e.g. Samaritans contact information). 
Timescale 
Submit ethics proposal July 2016 
Data Collection September 2016 – November 2016 Data analysis October 2016 – November 
2016 First Draft of literature review – September 2016 Second draft of literature review – 
October 2016 First Draft of empirical paper - January 2017 Second draft of empirical paper 
– February 2017 First Draft of critical review – March 2017 





Submit papers for publication – June/July 2017 
If accepted, submit final manuscript to research coordinator – July/August 2017 
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Appendix A: Qualtrics material (please note that the following information will all be in 
electronic format on the Qualtrics website). 
 
Step 1: Participants information sheet Participant Information Sheet 
 
Project Title: Decision making and risk in people diagnosed with bipolar disorder. 
 
My name is Anna Chiara Sicilia and I am conducting this research as a student on the 
Doctorate in Clinical Psychology programme at Lancaster University. 
 
What is the study about? 
 
The purpose of this study is to explore the links between the way in which people diagnosed 
with bipolar disorder make sense of their daily experiences and make decisions and their 
likelihood of taking risks in everyday life. 
Bipolar disorder has been associated with a higher likelihood of engaging in risky behaviour, 
particularly during periods of mania. This often leads to negative consequences both in the 
short and long-term. Understanding the reasons why bipolar disorder is associated with a 
higher likelihood of taking risks will help to obtain a deeper understanding of the condition 
as well as its clinical management. 
The study will involve eight (8) brief questionnaires focused around people’s perception of 
risk and risk taking, impulsivity and their current mood state. As you will see, some of the 
questionnaires ask about risks related to sexual activity; BUT the aim of the study is not to 
find out about your sexual life. Risk associated with sexual life is just one example of many 
candidate risk behaviours. We are only interested in your attitudes and thinking around “the 
risks” associated with engaging in sexual activity. 
 
Please note that it is possible to pause and save at any time during the study, therefore if you 








Why have I been approached? 
You have been approached because the study requires information from people who have 
been diagnosed with bipolar disorder. 
 
Do I have to take part? 
No. It’s completely up to you to decide whether or not you take part. There will be no 
negative consequences if you decide not to participate. 
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you would be asked to complete eight (8) online 
questionnaires. This will last approximately 35-50 minutes and can be done from home at a 
time that is suitable for you. 
 
Will my data be Identifiable? 
The information you provide is anonymous. No identifiable information (e.g. any names, date 
of birth 
and other information that might identify you) will be reported in the final report. The data 
collected for this study will be stored securely and only the researchers conducting this study 
will have access to these data. 
The files on the computer will be encrypted (that is no-one other than the researcher and her 
university supervisors will be able to access them) and the computer itself password 
protected. All your personal data will be confidential and will be kept separately from your 
questionnaire responses. 
Please note that due to data being anonymous, it will not be possible to withdraw your data 
once your responses have been submitted through the online portal. 
What will happen to the results? 
The results will be summarised and reported in a final report for my thesis, which will be 
submitted for examination as part of my clinical psychology training. This may also be 







Are there any risks? 
There are no risks anticipated with participating in this study. However, if you experience 
any distress following participation you are encouraged to inform the researcher and contact 
the resources provided at the end of this sheet. 
 
Are there any benefits to taking part? 
Although you may find participating interesting, there are no direct benefits in taking part. 
 
Who has reviewed the project? 
This study has been reviewed by the Faculty of Health and Medicine Research Ethics 
Committee, and approved by the University Research Ethics Committee at Lancaster 
University. 
 
Where can I obtain further information about the study if I need it? 
If you have any questions about the study, please contact the main researcher: 





If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact: 
 
Dr Bill Sellwood (Research Director, Doctorate in Clinical Psychology, Lancaster 
University) b.sellwood@lancaster.ac.uk 
+441524593998 
Division of Health Research Furness Building 
Lancaster University 






If you wish to speak to someone outside of the Clinical Psychology Doctorate Programme, 
you may also contact: 
 
Professor Roger Pickup Tel: +44 (0)1524 593746 Associate Dean for Research 
Email: r.pickup@lancaster.ac.uk 
Faculty of Health and Medicine Division of Biomedical and Life Sciences 
Lancaster University Lancaster 
LA1 4YG 
 
Resources in the event of distress 
We are not expecting this study to cause you any distress. However, if you do experience 
distress following your participation in the study, we advise you to contact your GP and/or 
your care team, who can offer guidance and advice to best manage this. 
Here are also some useful resources you can access in case of distress: 
 
Mind UK 
You can contact Mind UK via email, phone, post or by visiting your local branch. 
Email: supporterservices@mind.org.uk 
Telephone: 020 8519 2122 






Find your local branch at the following link: http://www.mind.org.uk/information-
support/local-minds/ 





Step 2: Consent 
By proceeding to the next page you confirm that: 
 
1) You have read the information sheet and fully understand what is expected of you within 
this study;   
2) that your participation is voluntary and that there are no incentives for taking part in the 
study;   
3) you confirm that you understand that any information you give will remain anonymous;   
4) you consent for the data to be discussed with my supervisor at Lancaster University;   
5) you consent to Lancaster University keeping the anonymised data for a period of 10 years 
after the study has finished;     
6) You consent to taking part in the current study. 
	
Demographic information 
Thank you very much for consenting to participate in this study. The following set of 
questions will ask about demographic and clinical information. 
Please remember that if you need to take a break you can save your progress by closing the 
page and re-opening the study from the original link from which you accessed it. It is 
important that you have access to the original link as otherwise your progress may be 
lost. 
If you close and reopen the study from the original link, this should automatically take you 
back where you left off, and you should be able to continue with the next question 
Item 1: Gender 
Male Female Other 
Item 2: Please indicate your date of birth using the following format (DD/MM/YYYY) 
Numerical Value 









Voluntary: Part-time or Full-time  
Other (please specify) 
Item 4: Please indicate your marital status 
Single 
In a relationship  
Married/civil partnership  
Widowed  
Divorced/Separated  
Other (please specify) 
Item 5: What is your highest education level 
GCSEs 
A-levels (or similar)  
Undergraduate degree  
Masters degree (or similar)  
PhD/Doctorate 
Other (please specify) 
Item 6: Please indicate your ethnic background 
White British/White Other  




Other ethnic group (please specify) 
Item 7: Is English your native language? 
Yes 






Item 1: When did you receive a diagnosis of bipolar disorder (or similar)? 
In the past year 
In the past 2-5 years  
In the past 6-10 years  
In the past 11-15 years 
More than 16 years ago (please specify)  
Item 2: Please specify your diagnosis type  
Bipolar Type I 
Bipolar Type 2 
Bipolar Disorder Not Otherwise Specified  
Schizoaffective Disorder 
Other (please specify) 
Item 3: Since when do you think these problems with depression and mania started? 
Since I was 0-5 years old  
Since I was 6-13 years old  
Since I was 14-18 years old  
Since I was 19-25 years old  
Since I was 26-45 years old  
Since I was 46 to now 
Item 4: How many episodes of bipolar have you experienced since you were diagnosed: 
Between 0-5 episodes 
Between 6-10 episodes 
Between 11-20 episodes  
More than 20 episodes 
Item 5: Are you currently receiving any psychological intervention? 






Item 6: Are you currently on any medication for bipolar disorder and/or any other 
mental health condition (if YES, please indicate name and dosage, if known) 
Yes (please specify)  
No 
Item 7: Do you believe that you are currently experiencing a mood episode (depression, 
mania or both)? 
Yes  
No 
Item 7a (if YES to question 7): When did this start? 
In the past week In the past month 
In the past 3 months 
In the past 6 months In the past year 
Other (please specify) 
Item 7b (if NO to question 7): When did you last mood episode (depression, mania or 
both) terminate? 
A week ago  
A month ago  
3 months ago 
6 months ago  
A year ago 
Other (please specify) 
Item 8: Do you have any other mental health diagnoses? 
Yes (please specify)  
No 
Item 9: Do you have any medical conditions? (please select more than one option if 
applicable) 
HIV/AIDS 






Pulmonary disease  
Gastrointestinal disorder  
 Autoimmune disorder (e.g. lupus) 
Neurologic disorder  
Head trauma 
Chronic Pain disorder 
Endocrine disorder (e.g. Thyroid disease)  
Metabolic disorder (e.g. diabetes)  
Kidney disease 
Cancer 
Other (please specify) 
 
If HIV or STD are selected then the system will show the following message: 
Thank you very much for being honest in your responses and informing us of your 
medical condition. As you remember from the information sheet provided at the start 
of the study, we are interested in risk related to sexual activity. 
As you reported to have either HIV/AIDS or an STD, some of the questions specifically 
relating to HIV or STD may not be applicable to you. 
We ask that you please try to answer these questions in an hypothetical manner, i.e. as 
if you DID NOT already have HIV/AIDS or an STD. 
Thank you for your hard work so far. 
You may now proceed to the next section. 
Thank you message: 
The next section of the study will contain the first of the eight (8) brief questionnaires. 
If you need a break, please remember that it is possible to 
save and continue later. If you are ok continuing with the 








The mood disorder questionnaire (MDQ) 
 
Instructions: Please answer each question to the best of your ability. 
Answers are scored on a YES or NO scale. 
1. Has there ever been a period of time when you were not your usual self and... 
 
...you felt so good or so hyper that other people thought you were not your normal self or 
you were so hyper that you got into trouble? 
...you were so irritable that you shouted at people or started fights or arguments? 
...you felt much more self-confident than usual? 
...you got much less sleep than usual and found you didn’t really miss it? 
...you were much more talkative or spoke much faster than usual? 
...thoughts raced through your head or you couldn’t slow your mind down? 
...you were so easily distracted by things around you that you had trouble concentrating or 
staying on track? 
...you had much more energy than usual? 
...you were much more active or did many more things than usual? 
...you were much more social or outgoing than usual, for example, you telephoned friends 
in the middle of the night? 
...you were much more interested in sex than usual? 
...you did things that were unusual for you or that other people might have thought were 
excessive, foolish, or risky? 
...spending money got you or your family into trouble? 
2. If you checked YES to more than one of the above, have several of these ever 
happened during the same period of time? 
3. How much of a problem did any of these cause you – like being unable to work; 
having family, money or legal troubles; getting into arguments or fights? 
Please circle one response only. 
No Problem Minor Problem Moderate Problem Serious Problem 
4. Have any of your blood relatives (i.e. children, siblings, parents, grandparents, 
aunts, uncles) had manic- depressive illness or bipolar disorder? 






Thank you message: 
Well done for completing the first questionnaire. 
Thank you very much for your hard work, we really appreciate your efforts in answering 
the questions so far. 
Please proceed to the next page for the next questionnaire. 
 
The 7 Up 7 Down Inventory 
 
Below are some questions about behaviors that occur in the general population. Using 
the scale below, select the number that best describes how often you have experienced 
these behaviours during the past two weeks. Please only select one number per item. 
For each item please choose between the following four options: 
 
0 – Never or hardly ever 1 – Sometimes 2 – Often 3 – Very often or almost constantly 
1. Have you had periods of extreme happiness and intense energy lasting 
several days or more when you also felt much more anxious or tense 
(jittery, nervous. uptight) than usual (other than related to the 
menstrual cycle)? 
0 1 2 3 
2. Have there been times of several days or more when you were so sad 
that it was quite painful or you felt that you couldn't stand it? 
0 1 2 3 
3. Have there been times lasting several days or more when you felt you 
must have lots of excitement, and you actually did a lot of new or 
different things? 
0 1 2 3 
4. Have you had periods of extreme happiness and intense energy 
(clearly more than your usual self) when, for several days or more, it 
took you over an hour to get to sleep at night? 
0 1 2 3 
5. Have there been long periods in your life when you felt sad, 
depressed, or irritable most of the time? 
0 1 2 3 
6. Have you had periods of extreme happiness and high energy lasting 
several days or more when what you saw, heard, smelled, tasted, or 
touched seemed vivid or intense? 
0 1 2 3 
7. Have there been periods of several days or more when your thinking 
was so clear and quick that it was much better than most other 
people's? 
0 1 2 3 
8. Have there been times of a couple days or more when you felt that 
you were a very important person or that your abilities or talents were 
better than most other people's? 
0 1 2 3 
9. Have them been times when you have hated yourself or felt that you 
were stupid, ugly, unlovable, or useless? 
0 1 2 3 
10. Have there been times of several days or more when you really got 
down on yourself and felt worthless? 
0 1 2 3 
11. Have you had periods when it seemed that the future was hopeless 
and things could not improve? 
0 1 2 3 
12. Have there been periods lasting several days or more when you were 
so down in the dumps that you thought you might never snap out of 
it? 





13. Have you had times when your thoughts and ideas came so fast that 
you couldn't get them all out, or they came so quickly that others 
complained that they couldn't keep up with your ideas? 
0 1 2 3 
14. Have there been times when you have felt that you would be better 
  off dead?   
0 1 2 3 
	
Thank you message: 
Well done for completing the second questionnaire. 
Thank you very much for your hard work, we really appreciate your efforts in answering the 
questions so far. 
Please proceed to the next page for the next questionnaire. 
Gist Scales  
Categorical Risk Scale 
Each item of this questionnaire is a statement that a person may either agree with or disagree 
with.  For each item, please choose the response that best represents your position about the 
risks of sexual activity. Please respond to all the items; do not leave any blank.  Choose only 
one response to each statement. 
Please be as accurate and honest as you can be.  Respond to each item as if it were the only 
item.  That is, don't worry about being "consistent" in your responses.  Choose from the 
following five response options: 
0 = strongly disagree 1 = disagree 2 = neither agree nor disagree 3 = agree 4 = strongly agree 
1. Even low risks happen to someone 0 1 2 3 4 
2. It only takes ONCE to get pregnant or get an STD 0 1 2 3 4 
3. Once you have HIV-AIDS, there is no second chance 0 1 2 3 4 
4. Even if you use condoms, eventually you’ll get an STD if you 
have sex enough 
0 1 2 3 4 
5. Even low risk adds up to 100% if you keep doing it 0 1 2 3 4 
6. If you keep having unprotected sex, risk adds up and you WILL 
get an STD 
0 1 2 3 4 
7. If you can’t handle getting protection, you are not ready for sex 0 1 2 3 4 
8. When in doubt about having sex, delay or avoid it 0 1 2 3 4 
9. If you keep having unprotected sex, risk adds up and you WILL 
get pregnant or get someone pregnant 






Gist Principles Scale 
 
Each item of this questionnaire is a statement that a person may either agree with or 
disagree with.  For each item, please choose the response that best represents your position 
about the risks of sexual activity. Please respond to all the items; do not leave any blank.  
Choose only one response to each statement. 
Please be as accurate and honest as you can be.  Respond to each item as if it were the only 
item.  That is, don't worry about being "consistent" in your responses. 
 
1. Avoid risk Agree Disagree 
2. Better to be safe than sorry Agree Disagree 
3. I have a responsibility to myself to wait to have sex Agree Disagree 
4. I have a responsibility to my 
parents/family to not have sex 
Agree Disagree 
5. Better to not have sex than hurt my parents/family Agree Disagree 
6. I have a responsibility to my partner to 
not put him/her at risk 
Agree Disagree 
7. I have a responsibility to God to wait to have sex Agree Disagree 
8. Better to not have sex than risk getting HIVAIDS Agree Disagree 
9. Better to not have sex than risk getting pregnant or getting 
someone pregnant 
Agree Disagree 
10. Better to focus on school than have 
sex 
Agree Disagree 
11. Better to wait than to have sex when you are not ready Agree Disagree 
12. Better to have fun (sex) while you can (R) Agree Disagree 
13. Having sex is 
better than losing a relationship (R) 
Agree Disagree 
14. Having sex is worth risking pregnancy (R) Agree Disagree 
15. Known partners are safe partners (R) Agree Disagree 
 
Global Risk Question 
 
Please choose the response that best represents your position about your current 
behaviour regarding sexual activity.  Overall for YOU which of the following best 
describes the RISK of having sex (circle one): 









Specific Risk Scale 
Each item of this questionnaire is a statement that a person may either agree with or 
disagree with.  For each item, please choose the response that best represents your position 
about the risks of sexual activity. Please respond to all the items; do not leave any blank.  
Choose only one response to each statement. 
Please be as accurate and honest as you can be. Respond to each item as if it were the only 
item. That is, don't worry about being "consistent" in your responses. Choose from the 
following five response options: 0 = strongly disagree 
1 = disagree 
2 = neither 
agree nor 
disagree 3 = 
agree 
4 = strongly agree 
1. I am likely to get pregnant (or get someone pregnant) in the next 6 
months 
0 1 2 3 4 
2. I am likely to have an STD in the next 5 years 0 1 2 3 4 
3. I am likely to have an STD in the next 6 months 0 1 2 3 4 
4. I am likely to have HIV-AIDS in the next 5 years 0 1 2 3 4 
5. I am likely to have HIV-AIDS in the next 6 months 0 1 2 3 4 
 
Quantitative Risk Question (from 0 to 100) 







Thank you message: 
 
Well done for completing the questionnaires so far. 
Thank you very much for your hard work, we really appreciate your efforts in answering 
the questions so far. 
If you feel like you need a break, please remember that you can save and continue the study 
later by closing this page and re-opening the study from the original link from which you 
accessed it. It is important that you have access to the original link before closing the 
study, otherwise your progress may be lost. 
 





BIS-11 Simplified (Barratt Impulsivity Scale) 
People differ in the ways they act and think in different situations. This is a test to measure 
some of the ways in which you act and think. Read each statement and select the answer 
that is most appropriate for you. Do not spend too much time on any statement. Answer 
quickly and honestly. 
Items will be scored using the following scale: 
 
1= Rarely/Never 2=Occasionally 3=Often 4=Almost Always/Always 
 
1. I act on impulse. 
2. I act on the spur of the moment. 
3. I do things without thinking. 
4. I say things without thinking. 
5. I buy things on impulse. 
6. I plan for job security. 
7. I plan for the future. 
8. I save regularly. 
9. I plan tasks carefully. 
10. I am a careful thinker. 
11. I am restless at lectures or talks. 
12. I concentrate easily. 
13. I don’t pay attention. 



























DOSPERT – Risk Taking Subscale 
 
For each of the following statements, please indicate the likelihood that you 
would engage in the described activity or behavior if you were to find yourself 
in that situation. Provide a rating from Extremely Unlikely to Extremely Likely, 
using the following scale: 
 
 
1 2 3 4 5 	 6 	 7 	
Extremely Moderately Somewhat Not Sure 	 Somewhat 	 Moderately 	 Extremely 
Unlikely Unlikely Unlikely 	 	 Likely 	 Likely 	 Likely 
 
1. Admitting that your tastes are different from those of a friend. (S) 
2. Going camping in the wilderness. (R) 
3. Betting a day’s income at the horse races. (F) 
4. Investing 10% of your annual income in a moderate growth mutual fund. (F) 
5. Drinking heavily at a social function. (H/S) 
6. Taking some questionable deductions on your income tax return. (E) 
7. Disagreeing with an authority figure on a major issue. (S) 
8. Betting a day’s income at a high-stake poker game. (F) 
9. Having an affair with a married man/woman. (E) 
10. Passing off somebody else’s work as your own. (E) 
11. Going down a ski run that is beyond your ability. (R) 
12. Investing 5% of your annual income in a very speculative stock. (F) 
13. Going whitewater rafting at high water in the spring. (R) 
14. Betting a day’s income on the outcome of a sporting event (F) 
15. Engaging in unprotected sex. (H/S) 
16. Revealing a friend’s secret to someone else. (E) 
17. Driving a car without wearing a seat belt. (H/S) 
18. Investing 10% of your annual income in a new business venture. (F) 
19. Taking a skydiving class. (R) 
20. Riding a motorcycle without a helmet. (H/S) 
21. Choosing a career that you truly enjoy over a more secure one.11 (S) 
22. Speaking your mind about an unpopular issue in a meeting at work. (S) 
23. Sunbathing without sunscreen. (H/S) 
24. Bungee jumping off a tall bridge. (R) 
25. Piloting a small plane. (R) 
26. Walking home alone at night in an unsafe area of town. (H/S) 
27. Moving to a city far away from your extended family. (S) 
28. Starting a new career in your mid-thirties. (S) 
29. Leaving your young children alone at home while running an errand. (E) 
30. Not returning a wallet you found that contains $200. (E) 









DOSPERT – Risk Perception Subscale 
 
People often see some risk in situations that contain uncertainty about what the outcome or 
consequences will be and for which there is the possibility of negative consequences. 
However, riskiness is a very personal and intuitive notion, and we are interested in your 
gut level assessment of how risky each situation or behavior is. For each of the following 
statements, please indicate how risky you perceive each situation. Provide a rating from 
Not at all Risky to Extremely Risky, using the following scale: 
 
1 2 3 4 5 6 7 
Not at all Slightly Somewhat Moderately Risky Very Extremely 
Risky Risky Risky Risky 	 Risky Risky 
 
1. Admitting that your tastes are different from those of a friend. (S) 
2. Going camping in the wilderness. (R) 
3. Betting a day’s income at the horse races. (F) 
4. Investing 10% of your annual income in a moderate growth mutual fund. (F) 
5. Drinking heavily at a social function. (H/S) 
6. Taking some questionable deductions on your income tax return. (E) 
7. Disagreeing with an authority figure on a major issue. (S) 
8. Betting a day’s income at a high-stake poker game. (F) 
9. Having an affair with a married man/woman. (E) 
10. Passing off somebody else’s work as your own. (E) 
11. Going down a ski run that is beyond your ability. (R) 
12. Investing 5% of your annual income in a very speculative stock. (F) 
13. Going whitewater rafting at high water in the spring. (R) 
14. Betting a day’s income on the outcome of a sporting event (F) 
15. Engaging in unprotected sex. (H/S) 
16. Revealing a friend’s secret to someone else. (E) 
17. Driving a car without wearing a seat belt. (H/S) 
18. Investing 10% of your annual income in a new business venture. (F) 
19. Taking a skydiving class. (R) 
20. Riding a motorcycle without a helmet. (H/S) 
21. Choosing a career that you truly enjoy over a more secure one.11 (S) 
22. Speaking your mind about an unpopular issue in a meeting at work. (S) 
23. Sunbathing without sunscreen. (H/S) 
24. Bungee jumping off a tall bridge. (R) 
25. Piloting a small plane. (R) 
26. Walking home alone at night in an unsafe area of town. (H/S) 
27. Moving to a city far away from your extended family. (S) 
28. Starting a new career in your mid-thirties. (S) 
29. Leaving your young children alone at home while running an errand. (E) 
30. Not returning a wallet you found that contains $200. (E) 
 







Thank you message: 
Well done for completing the study so far and thank 
you for your hard work. 
The next questionnaire will be the LAST questionnaire of the study. We really 
appreciate your efforts in completing the questionnaires so far. 
Please continue to the next page. 
BIS/BAS 
Each item of this questionnaire is a statement that a person may either agree with or 
disagree with.  For each item, indicate how much you agree or disagree with what the 
item says.  Please respond to all the items; do not leave any blank. Choose only one 
response to each statement. Please be as accurate and honest as you can be. Respond to 
each item as if it were the only item.  That is, don't worry about being "consistent" in your 
responses. Choose from the following four response options: 
1 = very true for me   2 = somewhat true for me   3 = somewhat false for me   4 = very 
false for me 
1 A person's family is the most important thing in life. 1 2 3 4 
2 Even if something bad is about to happen to me, I rarely experience fear 
or 
  nervousness.   
1 2 3 4 
3 I go out of my way to get things I want. 1 2 3 4 
4 When I'm doing well at something I love to keep at it. 1 2 3 4 
5 I'm always willing to try something new if I think it will be fun. 1 2 3 4 
6 How I dress is important to me. 1 2 3 4 
7 When I get something I want, I feel excited and energized. 1 2 3 4 
8 Criticism or scolding hurts me quite a bit. 1 2 3 4 
9 When I want something I usually go all-out to get it. 1 2 3 4 













12 If I see a chance to get something I want I move on it right away. 1 2 3 4 
13 I feel pretty worried or upset when I think or know somebody is angry 
at 
  me.   
1 2 3 4 
14 When I see an opportunity for something I like I get excited right away. 1 2 3 4 
15 I often act on the spur of the moment. 1 2 3 4 
16 If I think something unpleasant is going to happen I usually get pretty 
  "worked up."   
1 2 3 4 
17 I often wonder why people act the way they do. 1 2 3 4 





19 I feel worried when I think I have done poorly at something important. 1 2 3 4 













22 I have very few fears compared to my friends. 1 2 3 4 
23 It would excite me to win a contest. 1 2 3 4 
24 I worry about making mistakes. 1 2 3 4 
	
Thank you for completing the study. 
If you would like to leave some feedback about your experience of completing this study you can 
do so by using the box below.  
Please note that, although your feedback is valued and will be taken into account, we are unable 
to respond to any comments directly. This is to protect participants’ anonymity throughout the 
research project.  
Please remember to click the 'next' button at the bottom of this screen to 





You have now completed the study. 
Thank you very much for your participation. 
If you have any questions about the study, please contact the main researcher: 
Anna Chiara Sicilia a.sicilia@lancaster.ac.uk Room C34, Furness Building Lancaster 
University Lancaster 
LA1 4YG 
Resources in the event of distress 
We are not expecting this study to cause you any distress. However, if you do experience 
distress following your participation in the study, we advise you to contact your GP and/or 
your care team, who can offer guidance and advice to best manage this. 








You can contact Mind UK via email, phone, post or by visiting your local branch. 
  
Email: supporterservices@mind.org.uk 
Telephone: 020 8519 2122 











If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact: 
 
Dr Bill Sellwood (Research Director, Doctorate in Clinical Psychology, Lancaster 
University) b.sellwood@lancaster.ac.uk +441524593998 
Division of Health Research Furness Building 
Lancaster University Lancaster 
LA1 4YG 
If you wish to speak to someone outside of the Clinical Psychology Doctorate Programme, 
you may also contact:  
Professor Roger Pickup Tel: +44 (0)1524 593746 
Associate Dean for Research 
Email: r.pickup@lancaster.ac.uk 





Division of Biomedical and 









































Appendix B: Email to charity/support/advocacy group: 
 
To whom it may concern, 
 
Could you please circulate the following email to members of your support and/or 
advocacy groups? Please don’t hesitate to contact me would you require further 
information, 
  Best Wishes 




I am a trainee clinical psychology on the Doctorate in Clinical Psychology at Lancaster 
University. I am contacting you as I am currently recruiting participants for a study aiming 
at exploring the links between the way in which people diagnosed with bipolar 
disorder make sense of their daily experiences and make decisions and their 
likelihood to take risks in their everyday life. 
The study will involve eight (8) brief questionnaires focused around people’s perception 
of risk and risk taking, impulsivity and their current mood state. As you will see, some of 
the questionnaires ask about risks related to sexual activity; BUT the aim of the study is 
not to find out about your sexual life. Risk associated with sexual life is just one example 
of many candidate risk behaviours. We are only interested in your attitudes and thinking 
around “the risks” associated with engaging in sexual activity. 
 
Please note that it is possible to pause and save at any time during the study, therefore if 
you feel like you need a break, you will be able to continue the study at a later time. 
 
If you would like to participate, please click on the link below: 
 
https://lancasteruni.eu.qualtrics.com/jfe/form/SV_b7tap9F1Mvq5mFn 
Thank you very much for your collaboration, 
 












Appendix C: Approval Letter from Lancaster University Ethics Committee 
 
Applicant: Anna Sicilia 
Supervisor: Guillermo Perez 
Algorta Department: Health 
Research FHMREC Reference: 
FHMREC15136 
 






Thank you for submitting your research ethics amendment application for the above project 
for review by the Faculty of Health and Medicine Research Ethics Committee 
(FHMREC). The application was recommended for approval by FHMREC, and on behalf 
of the Chair of the Committee, I can confirm that approval has been granted for this 
research project. 
 










Please contact me if you have any queries or require further 






Dr Diane Hopkins 
Research Integrity and Governance Officer, Secretary to FHMREC.
	
	
	
 
